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ABSTRACT 
Harpagophytum procumbens DC [family: Pedaliaceae] is widely used in South African 
traditional medicine for the treatment, management and/or control of a variety of human 
ailments. In an attempt to scientifically appraise the 'healing powers' and medicinal 
value of Harpagophytum procumbens DC secondary root aqueous extract (HPE), and 
throw some light on the efficacy and safety of the medicinal plant product, the 
pharmacological effects of the plant's root aqueous extract (HPE) have been investigated 
on a number experimental animal models in vitro and in vivo. 
The results obtained in the studies reported in this thesis clearly indicate that 
Harpagophytum procumbens secondary root aqueous extract possesses a catalogue of 
pharmacological actions. The plant's aqueous extract (HPE, 10-1000 Ilg/ml) produced 
concentration-dependent, significant (P<0.05-0.001), atropine-sensitive contractions of 
mammalian and avian isolated gastro-intestinal smooth muscles. The plant's extract 
(HPE, 10-1000 Ilglml) also exhibited significant anticholinesterase activity. It is 
speculated that the contractile effects of Harpagophytum procumbens secondary root 
aqueous extract is mediated via cholinergic mechanism, possibly by stimulating 
cholinergic muscarinic receptors. 
Harpagophytum procumbens secondary root aqueous extract (HPE, 10-1000 Ilg/ml) also 
provoked concentration-related, significant (P<0.05-0.001), contractions on the rat 
isolated uterine muscles. This observation appears to justify the use of the herb's 
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secondary root extracts for induction and acceleration of labour by traditional birth 
attendants. However, because Harpagophytum procumbens secondary root aqueous 
extract induced powerful contractions of uterine muscle strips taken from both pregnant 
and non-pregnant rats, the use of the plant's extract should be contra-indicated and 
avoided in pregnant women. 
Harpagophytum procumbens secondary root aqueous extract produced a dose-related, 
slight but significant (P<0.05-0.001) hypotension in the arterial blood pressure of 
anaesthetized rats. The depressor effect of the plant's extract on the blood pressure of rats 
in vivo was resistant to atropine and mepyramine pretreatment. It was thought that the 
depressor effect could be due in part, to the vasorelaxant activity of the plant's extract, 
since Harpagophytum procumbens secondary root aqueous extract produced 
concentration-related, significant, secondary longer-lasting relaxations of the rat isolated 
portal vein. 
The plant's extract produced biphasic effects on guinea-pig isolated cardiac muscles. The 
responses of guinea-pig isolated atrial muscles to the plant's extract consisted of 
concentration-dependent initial slight positive inotropic and chrotropic effects followed 
by long-lasting, significant negative inotropic and chronotropic effects. It was observed 
that relatively high concentrations of Harpagophytum procumbens secondary root 
aqueous extract (HPE, 400-1000 J.!g!ml) always induced concentration-related, highly 
significant (P<0.01-0.001) negative inotropic and chronotropic responses of the guinea-
pig isolated atrial muscles. 
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In the two analgesic test methods used, the plant's extract (HPE, 50-800 mg/kg i. p.) 
produced dose-related analgesic effects. Although to a smaller extent, the analgesic 
effects of the plant's extract were comparable with those of morphine, diclofenac or 
aspirin. It is, therefore, suggested that the analgesic effects of plant's extract are probably 
mediated centrally and peripherally. 
Harpagophytum procumbens secondary root aqueous extract (HPE, 50-800 mg/kg i. p.) 
also produced dose-related, significant (P<0.5-0.001) anti-inflammatory activity against 
fresh egg albumin-induced inflammation in rats. Although qualitatively and 
quantitatively smaller, the anti-inflammatory effect of the plant's extract was comparable 
with that of diclofenac or aspirin. It is speculated that the plant's extract probably acts via 
a mechanism similar to those of the non-steroidal anti-inflammatory drugs (NSAIDs), i. 
e., by inhibiting cyclo-oxygenase and/or lipoxygenase, and thereby preventing the 
synthesis and release of inflammatory mediators such as prostaglandins. 
In mice, Harpagophytum procumbens secondary root aqueous extract (HPE, 50-800 
mg/kg i. p.) significantly delayed (P<0.5-0.001) the onset of seizures induced by 
pentylenetetrazole, picrotoxin and bicuculline. Since pentylenetetrazole- and picrotoxin-
induced seizures are known to occur as a consequence of inhibition or attenuation of 
GAB A neurotransmission and/or activity, it is speculated that the anticonvulsant activity 
of Harpagophytum procumbens secondary root aqueous extract might be due to 
potentiation or enhancement of GABA neurotransmission and/or activity by the plant's 
extract. 
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Harpagophytum procumbens secondary root aqueous extract (HPE, 50-800 mg/kg i. p.) 
produced dose-related, significant reductions in the blood glucose concentrations of 
streptozotocin-induced diabetic rats. The plant's extract also reduced the glucose levels of 
normal (normoglycaemic) rats. Although smaller, the hypoglycaemic and antidiabetic 
effects of the plant's extract are comparable to those of chlorpropamide in the 
experimental animal model used. It is speculated that Harpagophytum procumbens 
secondary root aqueous extract might be producing its hypoglycaemic and antidiabetic 
effects via mechanisms similar to those of sulphonylureas. 
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BACKGROUND AND RATIONALE 
Plants have been used for medicinal purposes in Africa for many centuries. Today, herbal 
products are being used worldwide in a variety of healthcare settings and as home 
remedies. Like other peoples in the world, Africans have long ago developed their own 
systems of healthcare delivery, including ways and means of classifying, diagnosing and 
treating diseases and illnesses. However, the history of 'Medicine and Healthcare' in 
Africa has been shaped by complex socio-economic and political factors. In Africa, the 
concept of 'health' and a 'healthy being' has always been perceived in the light of the 
World Health Organization's (WHO's, 2002) document which defines "health" as: "a 
state of complete physical, mental, social and psychological well being". 
There are millions of 'traditional heath practitioners' in Africa. For example, current 
estimates suggest that in South Africa, there is an approximate ratio of 1 :500 of 
traditional healers (i. e., traditional health practitioners) to the people of an estimated 
population of 44 million, whereas the ratio of Western health practitioners (i. e., 
physicians) to the people in the country is 1 :40000. Current estimates also suggest that in 
many African countries, a large proportion of the population (approximately 75%) still 





Although modem, Western healthcare systems may be available in these countries, herbal 
medicines (phytomedicines) have often maintained popularity among the people for 
historical, social, cultural and economic reasons. Moreover, the people, especially in the 
rural areas, are more likely to consult traditional healers first about their ailments because 
of the physical proximity. According to World Health Organization (WHO, 2002; 2003), 
'Traditional Medicine' may be defined as 'all knowledge and practices, understandable 
or not, that are used to diagnose, prevent, heal partially or completely, eliminate a 
physical, mental or social disorder ( imbalance), based exclusively on the day-to-day 
experience of the practitioner and the observationls transmitted orally or in writing, from 
generation to generation '. 
On the continent of Africa, only a few of the vast medicinal plants used as 
phytomedicines by traditional health practitioners have been subjected to scientific 
scrutiny and experimentation in laboratory animals and man, for their accredited 
medicinal values. Safety and efficacy data are not available for most of the commonly-
used medicinal plants, their extractives and bioactive chemical constituents, and the 
preparations containing them. Although many of the plants have ethnobotanical 
reputation for traditional medicinal usage, there is very little or no scientific information 
on their active constituents, pharmacological actions, and clinical efficacy. Growing 
interests and concerns have, therefore, prompted greater in-depth studies on the 
properties and uses of medicinal plant materials and products, and raised concerns about 
the safety, efficacy and quality of medicinal plants and herbal products generally. Both 






information on the safety and efficacy of medicinal plant products and traditional 
medicines made from the plants. In the interest of millions of people who rely on 
traditional medicines for their daily healthcare needs, it is, therefore, thought imperative 
to scientifically probe the frequently-used medicinal plants of South Africa, with a view 
to obtaining convincing data on the pharmacological actions, safety and efficacy of 
extractives obtained from the plants. 
The study reported in this thesis deals with some aspects of the pharmacology of 
Harpagophytum procumbens DC aqueous extract. 
HARP A GOPHYTUM PROCUMBENS DC ("DEVIL'S CLAW") 
Historical Background 
The German explorers in Namibia in the early 19th century, learned about the multi-
purpose and magnificent uses of ' harpago' from the Bushmen. The plant was thus taken 
(from Namibia) and introduced to Europe via Germany at the beginning of the 20th 
century, where attention has focused on its use as an anti-inflammatory and anti-
rheumatoid herb (Beresford, 2002). 
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Botanical Name: Harpagophytum procumbens DC 
Family: Pedaliaceae 
Vernacular (aka) Names: Devil 's claw, Grapple plant, Wood spider, Harpago 
Harpagophytum procumbens DC [family: Pedaliaceae] is a desert plant which is 
indigenous to southern Africa. It is found in abundance in the Kalahari desert and 
Namibian steppes where it has long been used as a folk remedy for the treatment of a 
variety of human ailments. The plant is also found in South Africa, Botswana, 
Zimbabwe, and to a very little extent, in some east African countries. Harpagophytum 
procumbens DC is a weedy, perennial plant with annual creeping stems spreading from a 
central, thick, fleshy, tuberous tap-root (Henderson and Anderson 1966; Van Wyk et al., 
2002; Van Wyk and Wink, 2004). The leaves are greyish-green and are usually 
irregularly divided into several lobes. The tubular flowers are either yellow and violet, or 
uniformly dark violet. The fruits have numerous characteristically long arms with sharp, 
grapple-like hooks (thorns), as well as two straight thorns on the upper surface (Watt and 
Breyer-Brandwijk, 1962; Van Wyk et aI., 2002; Van Wyk and Wink, 2004) - see Figure 
1. The plant is commonly referred to as 'Devil's claw', a name derived from its claw-like 
fruits which may cling tenaciously to the foot and other parts of an animal's body and, is 
thus dispersed in this way (Watt and Breyer-Brandwijk, 1962; Van Wyk et aI., 2002). 
Devil's claw has been used for centuries by Africans as a folk remedy to treat a variety of 
human ailments, including skin cancer and lesions, fevers, gout, rheumatoid arthritis, 




Harpagophytum procumberu leaves and flowers Harpagophytum procumberu fruit 
Figure 1. 
Harpagophytum procumbens (Devil ' s claw). [Culled from Van Wyk and Wink, 2004]. 
stomach and kidneys (Beresford, 2002). In Europe, the root extract is recommended for 
arthritis, diabetes, allergies and senility, and is widely used as a digestive aid and appetite 
stimulant (Smith et ai., 2001). Devil's claw is widely used in European herbal tea 
formulations, and in recent years, many health food marketing centers carry formulations 
containing harpago extracts or root powders. The British and German Herbal 
Pharmacopoeias recognize Devil's claw as possessing analgesic, sedative and diuretic 
properties (Smith et ai., 2001). Also in Europe, a home remedy containing secondary 
roots of Devil's claw is used for lack of appetite, dyspeptic complaints and as a 
supportive therapy for degenerative disorders of the locomotor system (Smith et al., 
2001). Analgesic effects of the secondary roots of the plant have also been observed 
along with reductions in abnormally high cholesterol and uric acid levels. Harpago is 
reported to be useful in small joint pains. Current use of the herb in the Western world 
has focused on its application to painful conditions of the musculo-skeletal system and 
digestive problems (Smith et al., 2001). It is frequently found in prescriptions for arthritis 
of all sorts, for rheumatic complaints and for low back pain, especially associated with 
spondylosis, lumbago, sciatica, fibrositis, neuralgia and polymyalgia (Smith et ai., 2001). 
The thick, fleshy, tuberous secondary, tap roots of Harpagophytum procumbens are 
usually dried and used in South African traditional medicine. In the form of infusions, 
decoctions, tinctures, powders and extracts, H procumbens secondary tap root is used for 
a variety of health conditions. In South Africa, it has an ethnomedical reputation for 
efficacy in anorexia, indigestion, diabetes mellitus, hypertension, gout, fevers, skin 
cancer, infectious diseases (including tuberculosis), allergies, osteoarthritis, fibrositis and 
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rheumatism, being particularly effective in small joint diseases (Van Wyk and Gericke, 
2000). When taken on a regular daily basis, it has a subtle laxative effect. Small doses of 
the plant's secondary root extract are used for menstrual cramps, while higher doses 
assist in expelling retained placentas. Devil's claw is also used post-partum as an 
analgesic and to keep the uterus contracted. The dry, powdered tuberous root of the plant 
is used directly as a wound dressing, or it is mixed with animal fat or vaseline to make a 
wound-healing and burn-healing ointment. Commercial ointments and creams of H 
procumbens are applied topically for minor muscular aches and pains, and to painful 
joints (Watt and Breyer-Brandwijk, 1962; Van Wyk and Gericke, 2000; Van Wyk et ai., 
2002; Van Wyk and Wink, 2004). Serum cholesterol and uric acid levels are also reduced 
by H procumbens preparations (VanWyk and Gericke, 2000). 
Active Constituents 
The main active chemical constituents of Harpagophytum procumbens secondary root 
extract include: 
Iridoid Glycosides - (0.5 - 3%) - Figure 2. 
Harpagoside - Harpagoside was the first iridoid glycoside isolated from Harpagophytum 
procumbens secondary root in 1962, and is widely regarded as the main active constituent 












Structural fonnulae of harp ago side, harpagide and procumbide. [Culled from Van Wyk et 
al., 2002]. 
A third glycoside named 'procumbine' was also isolated in 1962 (Beresford, 2002). In 
1983, three additional iridoid glycosides with similar names, but having different 
linkages were discovered (Beresford, 2002). Iridoids are synthesized through mevalonic 
acid pathway, and are technically known as ' cyc1opentan-[c]-pyran monoterpenoids'. The 
aglycones of the iridoid glycosides have furane or pyrane structure (Beresford, 2002). By 
degradation of natural pentoses to furfuol, this gives rise, via furane-2-carbonic acid, to 
furane . The pyranes a-pyrane and gamma pyrane in their reactions resemble unsaturated 
aliphatic compounds, but the pyrylium salts derived from them are trebly unsaturated, 
and so are aromatic in character (Beresford, 2002). Some researchers believe that the 
therapeutic effects of the iridoid glycosides are due to furane and pyrane, the latter 
accepting hydrogen, and thus producing oxidation of the substrate, such as toxin 
(Beresford, 2002). Clinical studies have shown that the iridoid glycosides from 
Harpagophytum procumbens secondary root are hydrolysed into the pyridine 
monoterpene alkaloid 'aucubinine B' by human faecal bacteria (Beresford, 2002). 
Flavonoids -
Mainly luteolin and kaempferol. 
Phenolic Acids -





Stigmasterol and p-sitosterol 
Sugars - (50%) 
Consisting mainly of the tetrasaccharide stachyose (up to 46%), smaller amounts of 
raffinose, sucrose and monosaccharides (Beresford, 2002). With the absence of starch 
and high molecular weight polysaccharides, the sugars serve as reserve carbohydrate and 
lead to an unusually high water-soluble fraction of 50-70% (Beresford, 2002). 
Triterpenes -
Oleanolic, ursolic and 3p-acetyloleanolic acid derivatives. 
Other Compounds -
Acetosides, esters and minerals. 
Pharmacology 
Many studies have been conducted on laboratory animals and man over the last three-to-
four decades, in an effort to scientifically validate the effectiveness of Harpagophytum 
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procumbens secondary root extract (and the iridoid glycoside, harpagoside) as an anti-
inflammatory, anti-rheumatic and analgesic agent. The results of these studies have been 
conflicting (Beresford, 2002). As a result of these conflicting findings, several 
investigators have cited a lack of quality control (standardization) of the preparations 
used in the various studies, and the inactivation of Harpagophytum procumbens 
secondary root extracts in the stomach when the extracts are administered orally - due to 
deactivation of its active chemical constituents by gastric acid juices - as possible causes 
of the discrepancies. There is some evidence to support the latter view, with research 
indicating that the anti-inflammatory and analgesic effects of the plant's root extracts 
were abolished following an acid treatment in order to reproduce the physico-chemical 
conditions found in the stomach. The same acid treatment also abolished the analgesic 
effects of harpagoside, suggesting that it is also degraded by gastric acid (Lanhers et ai., 
1992). 
One area where researchers seem to be in agreement is that the iridoid glycoside 
harpagoside does not appear to be involved in the anti-inflammatory properties of 
Harpagophytum procumbens secondary root extracts (Lanhers et ai., 1992; Beresford, 
2002). In addition, while harp ago side appears to exhibit some analgesic activity, this 
effect was about 42% less than that of the whole plant extract, suggesting that other 
compounds in the plant must also be involved in the analgesic activity (Lanhers et ai., 
1992; Beresford, 2002). 
The mechanism underlying the anti-inflammatory and anti-arthritic actions of 
Harpagophytum procumbens secondary root extracts is unclear. Research conducted in 
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the early 70s indicated that the plant's anti-arthritic action was due to the redox potential 
of the iridoid glycosides. However, more recent studies have indicated that the anti-
inflammatory action of the plant's extracts does not appear to involve the arachidonic 
acid cascade and prostaglandins, as do conventional NSAIDs such as indomethacin 
(Lanhers et ai., 1992; Beresford, 2002). It is speculated that the analgesic action of 
Harpagophytum procumbens secondary root extracts may be due to a complex 
interaction between the various chemical constituents of the plant, thus suggesting that 
the compounds, especially harpagoside, interfere with the mechanisms which regulate 
calcium mobilization and sequestration in the cells. 
Anti-oxidant Activity 
Recent investigations have centred on the possibility that Harpagophytum procumbens 
secondary root extract possesses significant anti-oxidant action, and that this action may 
explain some of its other actions and effects, particularly the anti-inflammatory and anti-
rheumatic actions (Beresford, 2002). There is substantial evidence that oxidative free 
radicals may be responsible for the induction of inflammation, and this may be an 
important aetiological factor in the genesis of inflammatory disease, such as rheumatoid 
arthritis (RA). Oxidative free radicals produced by polymorphonuclear leukocytes, and 
possibly other sources also, contribute to the complex pathogenesis of arthritic disease. 
Thus, they activate prostaglandin synthesis, and cause direct cellular damage or injury, 
13 
altering the biochemical, biophysical and structural properties of cellular proteins, 
including elastin, collagen and polysaccharides; degrading cartilage and reducing the 
viscosity of synovial fluid (Beresford, 2002). It has been shown that RA has many 
characteristics of a free-radical induced disease. The human synovial tissue has no anti-
oxidant protection in the form of superoxide dismutase (SOD), catalase (CAT) or 
glutathione peroxidase (GPX), to protect against potential damage induced by oxygen 
free radicals. This would include lipid peroxidation and its consequences (Beresford, 
2002). Experimental studies have shown that Harpagophytum procumbens secondary 
root extract possesses anti-oxidant activity similar to those of standard anti-oxidant 
agents. This anti-oxidant property may be responsible for the experimental and clinical 
anti-inflammatory activity of the herb (Beresford, 2002). This anti-oxidant activity of 
Devil 's claw may also explain some of the other reported actions of the plant's secondary 
root extract, including its inhibitory effects on smooth, cardiac and skeletal muscles, and 
interfere with mechanisms that regulate the influx of calcium ions into cells. Perfusion 
injury following myocardial infarction is associated with an accumulation of oxidative 
free radicals (Beresford, 2002). Anti-oxidants have been shown to be effective in 
preventing or reducing such injury. Similarly, increased cellular calcium influx following 
lipid peroxidation of the cell membrane, may be involved in the mechanisms underlying 
cell damage or injury (Beresford, 2002). 
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Digestive Activity 
Harpagophytum procumbens secondary root is reported to have a bitter action, 
equivalent to that of gentian root (Beresford, 2002). Much of this effect is thought to be 
due to its iridoid glycosides which cause reflex stimulation of the digestive processes. 
Recent studies have also shown that the plant product activates liver function, promoting 
detoxification of toxins such as urea (Beresford, 2002). Furthermore, the plant has been 
shown to be a useful remedy for reducing elevated cholesterol and neutral fat levels in 
patients with metabolic disorders (Beresford, 2002). Published research findings have 
shown beneficial effects of Harpagophytum procumbens secondary root in the treatment 
of a wide range of digestive disturbances, including dyspeptic conditions of the upper 
epigastrium, intestinal upsets, and liver and gall bladder complaints with or without 
pancreatic involvement (Beresford, 2002). 
ImmuDomodulatory Activity 
Harpagophytum procumbens secondary root has been shown to possess significant 
immunomodulatory activity, and according to traditional Indian medicine, the plant is a 
good stimulant for the lymphatic system (Beresford, 2002). 
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Toxicology 
Harpagophytum procumbens secondary root is considered to be very safe in experimental 
animals and human beings (Beresford, 2002). 
Contra-indications 
Harpagophytum procumbens secondary root is said to have oxytocic properties and 
should be avoided in pregnancy. Furthermore, because of its reflex effect on digestive 
system, the use of the plant should be avoided in patients with gastric or duodenal ulcers 
(Beresford, 2002). 
16 
AIMS OF THIS STUDY 
Although Harpagophytum procumbens DC secondary tap root is widely used in South 
African traditional medicine for the treatment, management and/or control of a variety of 
human ailments, very little or no scientific data exists in the literature on the efficacy, 
safety and quality of the plant product. Biomedical literature is also very sparse on the 
pharmacological actions of the herb in man or in laboratory animals. Since many people 
still use Harpagophytum procumbens DC secondary root daily for their health conditions, 
it has become imperative to scientifically scrutinize the 'healing powers' of the plant, 
appraise and validate the ethnomedical claims of traditional healers on the herb, and 
throw more light on the efficacy and safety of the medicinal plant product. To meet the 
above objectives, the pharmacological effects of the plant's root aqueous extract (HPE) 
have been investigated on organ-systems and various tissues, including isolated gastro-
intestinal muscle strips, cardiac muscle preparations and also on the cardiovascular 
system of some laboratory animals. It was also thought that such experimental, laboratory 
animal studies would probably provide rational explanations and pharmacological basis 




GASTRO-INTESTINAL SMOOTH MUSCLE PHARMACOLOGY OF 
HARPAGOPHYTUM PROCUMBENS DC 
ABSTRACT 
Harpagophytum procumbens DC is widely used in South African traditional medicine for 
the treatment, management and/or control of a variety of human ailments. In an attempt 
to scientifically appraise the 'healing powers' and medicinal value of Harpagophytum 
procumbens DC secondary root aqueous extract (HPE) , and throw some light on the 
efficacy and safety of the medicinal plant product, the pharmacological effects of the 
plant's root aqueous extract (HPE) on chick, guinea-pig and rabbit isolated gastro-
intestinal smooth muscle preparations, and rat isolated uterine muscle strips have been 
examined. The results of this in vitro laboratory animal study indicate that relatively low 
to high doses of Harpagophytum procumbens root aqueous extract (HPE, 10-1000 
/-lglml) provoked concentration-related, atropine-sensitive, significant (P<0.05-0.00 1) 
contractions of the chick isolated oesophagus, guinea-pig isolated ileum and rat uterine 
muscle preparations. 
Relatively moderate to high concentrations of the plant' s extract (HPE, 200-1000 /-lglml) 
always produced concentration-dependent, biphasic effects on rabbit isolated duodenum. 
Relatively low concentrations of the plant' s extract (HPE, 10-100 /-lglml) usually caused 
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an initial slight, transient and non-significant (P>0.05) increase in the amplitude of the 
spontaneous, myogenic, rhythmic, pendular contractions of the rabbit duodenal muscle 
preparations. On the other hand, relatively moderate to high concentrations of the plant's 
extract (HPE, 200-1000 Ilg/ml) always produced initial slight, significant (P<0.05-O.0l) 
reductions (inhibitions) of contractile amplitudes of the rabbit isolated duodenum. The 
initial slight depressions of the contractile amplitudes of the isolated rabbit duodenum 
caused by relatively moderate to high concentrations of the plant's extract (HPE, 200-
1000 Ilg/ml) were always followed by dose-related, significant (P<0.05-0.00l) elevated 
baseline tones (tensions) and augmentations of the contractile amplitudes; and then 
secondary, longer-lasting relaxations and reductions of the contractile amplitudes of the 
spontaneous, rhythmic, myogenic, pendular contractions of the rabbit isolated duodenal 
muscle preparations. 
Some traditional birth attendants in South Africa have claimed that Harpagophytum 
procumbens DC secondary root is a useful obstetric remedy for the induction or 
acceleration of labour, as well as for expUlsion of retained placentas in pregnant women. 
In the present study, therefore, the pharmacological effects of Harpagophytum 
procumbens secondary root aqueous extract (HPE) have been examined on isolated 
uterine muscle strips taken from pregnant and non-pregnant, young female rats. The 
plant's extract (HPE, 10-1000 Ilg/ml) induced concentration-related, significant (P<0.05-
0.001) increases in the baseline tone (basal tension) and caused powerful spontaneous, 
rhythmic, myogenic contractions of the oestrogen-dominated uterine muscle strips taken 
from stilboesterol-pretreated, non-pregnant female rats. Relatively low to high 
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concentrations of Harpagophytum procumbens secondary root aqueous extract (HPE, 10-
1000 llg/m1) also provoked concentration-related, significant (P<0.05-0.00 1) increases in 
the baseline tone (basal tension) and contracted uterine muscle strips taken from rats in 
the early, middle and late stages of pregnancy. Moderate to high concentrations of the 
plant's extract (HPE, 200-800 Ilg/ml) always provoked powerful contractions of the 
uterine muscle preparations. The results of this in vitro study indicate that 
Harpagophytum procumbens secondary root aqueous extract (HPE) possesses significant 
contractile effect and/or uterotonic action on mammalian uterus. This observation 
suggests that the use of Harpagophytum procumbens secondary root should be contra-
indicated and avoided in pregnancy. 
In a separate set of experiments involving the use of chick isolated biventer-cervicis and 
oesophagus muscle homogenates for colorimetric anticholinesterase determination, 
Harpagophytum procumbens (HPE, 10-1000 Ilg/ml) was found to possess 
anticholinesterase activity. In this regard, however, the plant's extract was found to be 
less potent than physostigmine. The anticholinesterase action of the plant's extract is 
speculated to contribute, at least in part, to the contractile effects of the herb's extract on 
the isolated gastro-intestinal and uterine smooth muscle preparations used in this study. 
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INTRODUCTION 
Reports on extra-vascular and vascular smooth muscle pharmacology of Harpagophytum 
procumbens DC secondary root extracts are very scanty in the literature. Occhiuto et al. , 
(1985) examined the effects of methanolic extract of Harpagophytum procumbens DC 
secondary roots and two of its active constituents, harpagoside and harpagide, on rabbit 
isolated duodenum and guinea-pig isolated ileum. The investigators observed that low to 
moderate concentrations of Harpagophytum procumbens secondary root extract (20-80 
Jlg/ml) increased the basal tone of the gastro-intestinal smooth muscle preparations in a 
concentration-dependent manner. Occhiuto et al., (1985) concluded that the action of 
Harpagophytum procumbens root extract on the non-vascular smooth muscle 
preparations is due to a complex interaction between the various active principles of the 
plant, and then suggested that the plant's active constituents, especially harpagoside, 
interfere with the mechanisms that regulate the influx of calcium in the cells. Besides this 
pioneering work of Occhiuto et al., (1985), to the best of our knowledge, there is no other 
report in the literature, on the extra-vascular smooth muscle effect of Harpagophytum 
procumbens DC secondary root extract. Therefore, it was thought worthwhile 
investigating the effects of Harpagophytum procumbens DC secondary root aqueous 
extract on the chick isolated parasympathetic ally-innervated oesophageal smooth muscle 
preparation, guinea-pig isolated ileum, rabbit isolated duodenum and rat isolated uterine 
smooth muscles, with a view to meeting the following aims and objectives: 
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AIMS OF THIS STUDY 
The studies reported in this section of the thesis were carried out in order to: 
1. systematically study the effects of Harpagophytum procumbens DC secondary 
root aqueous extract (HPE) on a range of isolated smooth muscle preparations 
that have been, and that have not been, previously reported in the literature (for 
example, the chick oesophagus, and rat uterus) ; 
2. elucidate the plausible mechanisms of action of Harpagophytum procumbens DC 
secondary root aqueous extract in the various isolated muscle preparations used; 
3. examine the hypothesis that the uterotonic action of Harpagophytum procumbens 
DC secondary root aqueous extract may involve prostaglandin release; 
4. examine if some of the commonly-reported adverse effects of the plant product 
(for example, gastro-intestinal disturbances and/or upsets) could be explained by 
an action on gastro-intestinal smooth muscles; 
5. substantiate or deny the findings ofOcchiuto et al., (1985). 
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MATERIALS AND METHODS 
Plant Material 
Fresh pieces of Harpagophytum procumbens DC secondary roots were purchased from 
Upington 'Muthi' Market in the Northern Cape Province of South Africa (between 
November, 2001 and March, 2003). The roots were identified by the staff of the North-
West University's Botany Department as the secondary roots of Harpagophytum 
procumbens DC [family: Pedaliaceae]. Voucher specimen of the plant's secondary roots 
have been deposited in the University' s Herbarium. 
Preparation of Harpagophytum procumbens Root Aqueous Extract 
One kilograrnme (1 kg) of fresh secondary roots of H procumbens were sliced and air-
dried at room temperature. The sliced, air-dried roots of the plant were ground into fine 
powder in a Waring commercial blender. The powder was Soxhlet extracted twice, on 
each occasion with 2.5 litres of distilled water at room temperature for 24 hours with 
shaking. The combined aqueous extracts were filtered and concentrated to dryness under 
reduced pressure at 30±I°C. The resulting aqueous extract was freeze-dried, finally 
giving 15.56 g [i. e., 1.556% yield] of a light-brown, powdery crude aqueous extract of 
Harpagophytum procumbens secondary root. Aliquot portions of the crude root aqueous 
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extract residue were weighed and dissolved in distilled water for use on each day of 
our experiment. 
Animal Material 
Young adult, white albino rabbits of both sexes weighing 1.5-3.0 kg; male and female 
Dunkin-Hartley guinea-pigs weighing 300--450 g; young adult, female Wistar rats (Rattus 
norvegicus) weighing 250-300 g, and young chicks (aged between 3 and 10 days after 
hatching) weighing 50-75 g; were used. The animals were kept and maintained under 
laboratory conditions of temperature, humidity, and 12-hour light: 12-hour night cycle; 
and were allowed free access to food and water ad libitum. 
A. Effects of Harpagophytum procumbens Root Aqueous Extract on 
Chick Isolated Parasympathetically-Innervated Oesophagus 
Young chicks (aged between 3 and 10 days after hatching) were starved overnight (to 
empty their crops) and killed by deep petroleum ether inhalation. The upper oesophagus, 
as far as the crop, was carefully prepared together with as much as possible of the right 
parasympathetic nerve trunk which runs along the course of the jugular vein. 
Parasympathetically-innervated oesophageal muscle strips were removed from the chicks 
according to the method of Bowman and Everett (1964). In each case, the tubular 
25 
segment (3-4 cm long) of the entire upper oesophagus was removed, set-up, treated and 
chemically- or electrically-stimulated under physiological conditions as described in 
detail earlier by Ojewole (1976). Each isolated oesophageal muscle strip was suspended 
in 30-ml 'Ugo Basile Two-Chambered Organ Baths' (model 4050) containing Krebs-
Henseleit physiological solution (of composition, in g/litre: NaCl, 6.92; KCI, 0.34; 
NaH2P04, 0.15; NaHC03, 2.1; MgCh, 0.11; CaCh, 0.26; and glucose, 1.00) maintained 
at 32±1°C and continuously aerated with carbogen (i. e., 5% carbon-dioxide + 95% 
oxygen gas mixture). Two oesophageal muscle preparations (one used as 'control' and 
the other one used as 'HPE- or drug-treated' preparation) were always set-up to allow for 
changes in the oesophageal muscle sensitivity. Each preparation was subjected to a 
resting tension of 1.0 g, and allowed to equlibrate for 30-45 minutes before it was 
challenged with HPE (and other drugs used) or electrically stimulated. Doses of HPE 
(and other drugs used) were added to the bath-fluid either cumulatively or sequentially 
(non-cumulatively), and washed out three-to-five times after the maximum responses of 
the tissues were attained. In the electrically-stimulated preparations, each tubular muscle 
strip was indirectly- stimulated through the parasympathetic (vagus) nerve trunk by 
means of bipolar platinum ring electrodes. Maximal contractions of the isolated muscle 
preparations were provoked with trains of square wave pulses of 0.5-1.0 msec duration at 
a frequency of 10-30 Hz and supramaximal voltages of 50-100 volts delivered from SRI 
square wave stimulators. Electrical stimulation usually lasted for 10 seconds, and was 
repeated where necessary, at regular intervals of 5-10 minutes. In some cases, 
concentrations of HPE (and other drugs used) were added sequentially to the bath-fluid 
26 
in-between electrical stimulations. Concentrations of bath-applied HPE (and other drugs 
used) were repeated where appropriate and/or possible, at regular intervals of 20-30 
minutes after the last washing. The electrically-induced contractions, as well as HPE-
(and other drugs-) induced responses of the muscle prepations were recorded 
isometrically by means of U go Basile force-displacement transducers, 2-Channel 
"Gemini" Recorder, and pen-recording micro dynamometers (model 7070). 
B. Effects of Harpagophytum procumbens Root Aqueous Extract on 
Guinea-Pig Isolated Ileum 
Tubular segments taken from distal ileum of guinea-pigs of either sex were prepared, 
isolated and set-up under physiological conditions as described in detail earlier by 
Ojewole (1976). Male and female Dunkin-Hartley guinea-pigs weighing 300--450 g were 
used. Each of the animals was killed by deep petroleum ether inhalation and bled out. 
Tubular pieces (3--4 cm long) taken from distal ileum of each animal were suspended in 
30-ml 'Ugo Basile Two-Chambered Organ Baths' (model 4050) containing Krebs-
Henseleit physiological solution maintained at 36±1°C and continuously aerated with 
carbogen (i. e., 5% carbon-dioxide + 95% oxygen gas mixture). Two ileal muscle 
preparations (one used as 'control' and the other one used as 'HPE- or drug-treated' 
preparation) were always set up to allow for changes in the ileal muscle sensitivity. The 
tissues were subjected to a resting tension of 1.0 g, and allowed to equlibrate for 30--45 
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minutes before they were challenged with doses of HPE (or other drugs used). Doses of 
HPE (and other drugs used) were added to the bath-fluid either cumulatively or 
sequentially, and washed out three-to-five times after the maximum responses of the 
tissues were attained. Concentrations ofHPE (and other drugs used) were repeated where 
appropriate and/or possible, at regular intervals of 20-30 minutes after the last washing. 
HPE- (and other drugs-) induced contractions and responses of the isolated ileal muscle 
preparations were recorded isometrically by means of U go Basile force displacement 
transducers, 2-Channel "Gemini" Recorder, and pen-recording microdynamometers 
(model 7070). 
c. Effects of Harpagophytum procumbens Root Aqueous Extract on 
Rabbit Isolated Duodenum 
Tubular segments (3-4 cm long) taken from the duodenum of young adult rabbits of 
either sex (weighing 1.5-3.0 kg) were prepared, isolated and set-up under physiological 
conditions as described in detail earlier by Ojewole (1976). Each of the animals used was 
killed by deep petroleum ether inhalation and bled out. The abdomen of the animal was 
quickly opened by a midline incision, and tubular pieces (3-4 cm long) of the duodenum 
were carefully cleaned free of connective, extraneous and fatty tissues, and then removed. 
The tubular pieces (3-4 cm long) were separately suspended in 30-ml 'Ugo Basile Two-
Chambered Organ Baths' (model 4050) containing Krebs-Henseleit physiological 
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solution maintained at 36±1°C and continuously aerated with carbogen (i. e., 5% carbon-
dioxide + 95% oxygen gas mixture). Two isolated duodenal preparations (one used as 
'control' and the other one used as 'HPE- or drug-treated' preparation) were always set 
up to allow for changes in the duodenal muscle sensitivity. Each of the isolated duodenal 
muscle preparations was allowed to equilibrate for a period of 30-45 minutes under an 
applied resting tension of 1.5-2.0 g, before it was challenged with concentrations of HPE 
(and other drugs used). Doses of HPE (and other drugs used) were applied to the bath-
fluid either cumulatively or sequentially, and washed out three-to-five times after the 
maximum responses of the tissues were attained. Concentrations of HPE (and other drugs 
used) were repeated where appropriate and/or possible, at regular intervals of 20-30 
minutes after the last washing. The amplitude and frequency (rate) of the spontaneous, 
myogenic, pendular, rhythmic contractions, as well as the HPE- (and other drug-) 
induced responses of the isolated muscle strips were recorded isometrically with the aid 
of Ugo Basile force-displacement transducers, 2-Channel "Gemini" Recorder, and pen-
recording microdynamometers (model 7070). 
D. Effects of Harpagophytum procumbens Root Aqueous Extract 
On Rat Isolated Uterine Muscles taken from Pregnant and Non-
Pregnant Female Rats: 
Young adult, female Wistar rats (Rattus norvegicus) weighing 250-300 g were used. The 
animals were kept and maintained under laboratory conditions of temperature, humidity, 
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and light; and were allowed free access to food (standard pellet diet) and water ad 
libitum. The animals were divided into two categories as follows: 
(i) Oestrogen-dominated, non-pregnant rats 
All the rats in this group were pretreated with stilboesterol (0.1 mg/kg s. c.) 20-24 hours 
before use (in order to induce oestrus state). Vaginal smears were taken immediately 
before the animals were sacrificed in order to ascertain that the animals were in oestrus 
state. Female rats in oestrus state were used in this set of experiments. 
(ii) Pregnant Rats 
Mated female rats were examined daily for the presence of cervical plug. The day on 
which cervical plug was first observed was taken as 'day one' of pregnancy of the female 
rat. Early pregnancy was regarded as day 1 to day 8, while late pregnancy was taken to be 
from day 16 to day 20 following cervical plug detection. 
Each of the pregnant and stilboesterol-pretreated non-pregnant female rats was killed by 
deep petroleum ether inhalation and bled out. The two uterine horns of the animal were 
cleaned free from fatty and connective tissues and trimmed. Tubular segments of 
approximately equal lengths (2-3 cm) were removed from the uterine horns by cutting 
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off both ends. The two tubular uterine-hom segments (2-3 cm long) were set-up under 
physiological conditions as described in detail earlier by Ojewole (1976). Each isolated 
uterine muscle strip was separately suspended in 30-ml 'Ugo Basile Two-Chambered 
Organ Baths' (model 4050) containing de Jalon's physiological solution (of composition, 
in g/litre: NaCI, 9.0; KCI, 0.42; CaCh, 0.06; MgCh, 0.005; NaHC03, 0.5; and glucose, 
0.5) maintained at 32±1°C and continuously aerated with carbogen (i. e., 5% carbon-
dioxide + 95% oxygen gas mixture). Two uterine hom muscle preparations (one used as 
'control' and the other one used as 'HPE- (or other drug-) treated test' preparation) were 
always set-up to allow for changes in the uterine muscle sensitivity. Each preparation was 
subjected to a resting tension of 1.0 g, and allowed to equilibrate for 30-45 minutes 
before it was challenged with HPE (and other drugs used). Doses of HPE (and other 
drugs used) were added to the bath-fluid either cumulatively or sequentially, and washed 
out three-to-five times after the maximum responses of the tissues were attained. Distilled 
water (the vehicle in which HPE and other drugs used in this study were dissolved) was 
used as the 'control' fluid for HPE and other drugs tested. Concentrations of bath-applied 
HPE (and other drugs used) were repeated where appropriate and/or possible, at regular 
intervals of 3-20 minutes after the last washing. HPE- (and other drug-) induced 
responses of the uterine muscle preparations were recorded isometrically by means of 
Ugo Basile force-displacement transducers, Ugo Basile's 2-Channel "Gemini" Recorder, 
and pen-writing microdynamometers (model 7070). 
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E. Determination of Anticholinesterase Activity 
Anticholinesterase activity of the plant's extract (HPE) was determined and compared 
with that of physostigmine by measuring the cholinesterase activity of the chick biventer-
cervicis (and chick oesophagus) muscle homogenates, using the colorimetric assay 
method of Ellman et al., (1961). Young chicks (aged between 3 and 10 days after 
hatching) were killed by deep petroleum ether inhalation. Their biventer-cervi cis (and 
oesophageal) muscles were removed as described in detail by Ojewole (1976). The 
isolated muscles were separately homogenized with an Ultra Turrax homogenizer (type 
TP18/2) for one minute, using 20 mg of tissue per ml of O.1M phosphate buffer (at pH 
8.0). The homogenate was filtered through a fine gauze into a 2S-ml glass flask immersed 
in ice. O.S ml of the homogenate was added to S.1 ml of phosphate buffer (at pH 8.0) in 
the glass flask, and incubated at 37°C for S minutes with shaking (by means of a 
mechanical shaker). After S minutes, 0.2 ml of a graded concentration of HPE (or 
physostigmine) was added, and the solution was further incubated for another IS minutes 
with shaking. Acetylthiocholine (0.2 ml; 1.0 mM) was added to serve as the substrate. 
Samples were taken at IS-minute intervals for the estimation of anticholinesterase 
activity. However, S minutes before sampling, 0.1 m1 of S,S-dithiobis-2-nitrobenzoic acid 
reagent was added to 2.9 ml of phosphate buffer (at pH 8.0) in a photocell, mixed gently, 
and then followed by addition of 0.2 ml of the incubated solution. 
Absorbance of the sample was read against a blank at wavelength 412 m/-!, using a 
Unicam SP600 spectrophotometer. The 'blank' solution was treated exactly in the same 
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way as the 'test' solution, except that the glass flask for the 'blank' solution contained 5.5 
ml phosphate buffer (at pH 8.0), 0.5 ml homogenate, but without anticholinesterase agent 
(i. e., HPE or physostigmine) or acetylthiocholine. The anticholinesterase determination 
is based on the following reactions: 
Acetylthiocholine - (cholinesterase enzyme)~ Thiocholine + acetate ...... (i) 
Thiocholine + dithiobisnitrobenzoate ~ Yellow colour ...... (ii) 
F. Analysis of Data 
Data obtained from 'test' groups of isolated muscle strips (chick oesophagus, guinea-pig 
ileum, rabbit duodenum and rat uterus) treated with Harpagophytum procumbens root 
aqueous extract (HPE) and other drugs used, and those obtained from distilled water-
treated 'control' isolated muscle preparations, were pooled, and expressed as means 
(±SEM). The difference between the plant extract (HPE)- or drug-treated 'test' means, 
and distilled water-treated 'control' means, was analyzed statistically. 'Student's t-test' 
(Snedecor and Cochrane, 1967), was used to determine the level of significance of the 
difference between the 'test' and 'control' group data means. Values of P ~ 0.05 were 
taken to imply statistical significance. 
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RESULTS 
The results obtained in this set of experiments demonstrate that Harpagophytum 
procumbens root aqueous extract possesses an array of pharmacological actions on extra-
vascular (i. e., non-vascular) smooth muscles, and confirm the findings of Occhiuto et at., 
(1985). 
Effects of Harpagophytum procumbens Root Aqueous Extract on Chick 
Isolated Parasym pathetically-Innervated Oesophagus 
Relatively low to high concentrations of Harpagophytum procumbens root aqueous 
extract (HPE, 10-1000 f.!g1ml) always raised the baseline tension (baseline tone) of, and 
contracted the chick isolated, parasympathetically-innervated oesophageal muscle 
preparations in a concentration-dependent manner. Furthermore, relatively small to high 
doses of the plant's extract (HPE, 50-1000 f.!g/ml) always produced dose-dependent, 
significant (P<0.05-0.00 1), atropine-sensitive contractions of the chick oesophageal 
muscle preparations. Figure 3 shows a typical trace, while Figure 4 summarizes the 
results obtained. Although qualitatively less, the chick oesophageal muscle contractions 
induced by moderate to high doses of the plant's extract (HPE, 50-1000 f.!g1ml) were 
comparable with those produced by acetylcholine (ACh, 0.1-5.0 f.!g/ml) and 
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Figure 3. 
Effects of graded concentrations of Harpagophytum procumbens secondary root aqueous 
extract (HPE) on chick isolated oesophagus. HPE 1, 2, 3, 4 and 5 represent 50, 100, 200 
400 and 800 I-lglml of Harpagophytum procumbens secondary root aqueous extract 
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Dose-response curves of graded concentrations of Harpagophytum procumbens 
secondary root aqueous extract (HPE, 10-800 Jig/ml) and acetylcholine (ACh, 0.01-10.0 
Jig/ml) on chick isolated oesophagus. Each point represents the mean (±SEM) of 6-8 
observations, while the vertical bars denote standard errors of the means. 
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Figure 5. 
Effects of Harpagophytum procumbens secondary root aqueous extract (HPE) on 
acetylcholine-(ACh-) induced contractions of the chick isolated oesophagus. Contractions 
of the muscle preparation were induced by acetylcholine (ACh, 0.5 j.lg/ml) sequentially 
added to the bath-fluid at the solid rectangles (.). HPE 1 and 2 represent 50 and 100 
j.lg/ml of Harpagophytum procumbens secondary root aqueous extract sequentially added 
to the bath-fluid at the solid dots (e) and solid upright-pointing arrows respectively. The 
two different concentrations of the plant's extract sequentially added to the bath-fluid 
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Figure 6. 
Effects of Harpagophytum procumbens secondary root aqueous extract (HPE) on 
electrically-induced contractions of the chick isolated oesophagus. Contractions of the 
muscle preparation were induced by indirect, electrical stimulation instituted at the solid 
letter S (30 Hz, 70volts). HPE 1 and 2 represent 50 and 100 /lglml of Harpagophytum 
procumbens secondary root aqueous extract sequentially added to the bath fluid at the 
solid dots (.) and solid upright-pointing arrows respectively. The two different 
concentrations ofthe plant's extract sequentially added to the bath-fluid were washed out 
at the adjacent, open right-hand-side downward-pointing arrows respectively. 
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Figure 7. 
Inhibitory effect of atropine (ATR., 1.0 J.lg/ml) on Harpagophytum procumbens 
secondary root aqueous extract (HPE)-induced contractions of the chick isolated 
oesophagus. At each of the solid dots (.), HPE (800 J.lglml) was sequentially added to 
the bath fluid. Atropine (ATR., 1.0 J.lglml) was added to the bath-fluid at the solid 
upright-pointing, left-hand-side arrow, and washed out at the adjacent, open right-hand-
side downward-pointing arrow. 
physosgmine (1.0-10.0 ~g/ml). Relatively low to high concentrations of the plant's 
extract (HPE, 10-1 000 ~g/ml) also potentiated and/or enhanced acetylcholine- (ACh, 
0.1-1.0 ~g/ml), physostigmine- (PHY, 0.5-5.0 ~g/ml) and electrical stimulation- induced 
contractions of the chick isolated oesophagus (Figures 5 and 6). Like acetylcholine-
(ACh-) and physostigmine-provoked contractions of the chick oesophageal muscle 
preparations, HPE-induced contractions of the chick isolated oesophagus muscle 
preparations were also dose-dependently reduced, inhibited or abolished by bath-applied 
atropine (0.1-2.5 ~g/ml) - see Figure 7. 
Effects of Harpagophytum procumbens Root Aqueous Extract on 
Guinea-Pig Isolated Ileum 
In the guinea-pig isolated ileal muscle preparations, the pharmacological effects of 
relatively low to high concentrations of Harpagophytum procumbens root aqueous 
extract (HPE, 10-1000 ~g/ml) were found to be similar to those produced by the plant's 
extract in the chick isolated oesophageal muscle preparations. However, HPE-induced 
responses of the guinea-pig isolated ileum were qualitatively and quantitatively smaller 
than those produced by the plant's extract in the chick isolated oesophagus. This 
observation appears to suggest that the chick oesophagus is more predominantly 
cholinergically-innervated than the guinea-pig ileum. 
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However, relatively low to high concentrations of Harpagophytum procumbens root 
aqueous extract (HPE, 10-1 000 ~glml) always raised the baseline tension (baseline tone) 
of, and contracted the guinea-pig isolated ileal muscle preparations in a concentration-
dependent manner. Furthermore, relatively moderate to high concentrations ofthe plant's 
extract (HPE, 200-1 000 ~glml) always produced concentration-dependent, significant 
(P<O.OS-O.OOI) and atropine-sensitive contractions of the guinea-pig ileal muscle 
preparations. Acetylcholine (ACh, 0.1-2.5 ~g/ml), physostigmine (PHY., 1.0-10.0 
~g/ml), histamine (HIST., 0,2-S.0 ~g/ml), S-hydroxytryptamine (S-HT, O.S-S.O ~glml), 
nicotine (0.5-10 ~glml) and potassium chloride (K+, S--40 mM) also contracted the 
guinea-pig isolated ileum in a concentration-related manner. Relatively low to high 
concentrations of the plant's extract (HPE, 10-1 000 ~g/ml) potentiated and enhanced 
acetylcholine- (ACh, 0.1-1.0 ~glml)-induced contractions of the guinea-pig isolated 
ileum in a concentration-related manner. Like acetylcholine- (ACh-) and physostigmine-
provoked contractions of the guinea-pig ileal muscle preparations, HPE-induced 
contractions of the guinea-pig isolated ileal muscle preparations were also dose-
dependently reduced, inhibited or abolished by bath-applied atropine (0.1-2.S ~glml). 
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Effects of Harpagophytum procumbens Root Aqueous Extract on 
Rabbit Isolated Duodenum 
Relatively low to high concentrations of Harpagophytum procumbens root aqueous 
extract (HPE, 10-1000 Ilg/ml) usually induced concentration-related complex, biphasic 
responses in rabbit isolated duodenum. Relatively moderate to high concentrations of the 
plant's extract (HPE, 200-1000 Ilg/ml) usually provoked dose-related, initial slight and 
transient, but significant (P<0.05-0.01) depressions of the amplitudes of the spontaneous, 
rhythmic, pendular contractions of the muscle preparations. These initial inhibitory 
effects of the plant's extract (HPE, 50-1000 Ilg/ml) were always immediately followed 
by sharp, significant (P<0.05-0.001) increases in the baseline tones (baseline tensions) of 
the muscle preparations. The increases in contractile amplitudes and baseline tones of the 
rabbit duodenal muscle preparations were always followed by gradual, dose-dependent, 
secondary, longer-lasting, significant (P<0.05-0.001) reductions in the amplitudes of the 
spontaneous, rhythmic, pendular contractions of the isolated muscle strips (Figure 8). The 
secondary, longer-lasting inhibitory effects of the plant's extract (HPE) were resistant to 
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Figure 8. 
Effects of Harpagophytum procumbens secondary root aqueous extract (HPE, 800 /-lg/ml) 
on contractile amplitudes of the spontaneous, myogenic, pendular, rhythmic contractions 
of the rabbit isolated duodenum. Harpagophytum procumbens secondary root aqueous 
extract (HPE, 800 /-lg/ml) was sequentially added to the bath-fluid at the solid dot (.) and 
solid, left-hand-side upright-pointing arrow; and washed out at the adjacent, open dot (0) 




Effects of Harpagophytum procumbens Root Aqueous Extract 
on Rat Isolated Uterine Muscles: 
(i) Oestrogen-dominated, non-pregnant uterine strips 
Uterine muscle strips taken from stilboesterol-pretreated, non-pregnant female rats were 
found to be quiescent and devoid of spontaneous, myogenic, rhythmic activity. However, 
relatively low to high concentrations of Harpagophytum procumbens secondary root 
aqueous extract (HPE, 10-1000 Ilglml) caused profound, concentration-related, and 
significant (P<O.OS-O.OOl) increases in the baseline tone (basal tension) and induced 
powerful spontaneous, rhythmic, myogenic contractions of the oestrogen-dominated 
uterine muscle strips taken from stilboesterol-pretreated, non-pregnant female rats. 
Moderate to high concentrations of the plant's extract (HPE, 200-800 Ilglml) always 
provoked powerful contractions of the uterine muscle preparations. Figure 9 illustrates a 
typical trace obtained, while Figure 10 summarizes the results obtained. Acetylcholine 
(ACh, 0.1-2.0 Ilglml) , physostigmine (PHY, 2.S-10.0 Ilg/ml), bradykinin (BKN, 1.0-
10.0 ,.,glml) and oxytocin (OTC, O.OS-O.S unit/ml) also induced powerful, concentration-
dependent, significant (P<O.OS-O.OOl) contractions of the oestrogen-dominated uterine 
muscle preparations taken from the oestrogen-dominated, non-pregnant rats. The 
spontaneous, rhythmic, myogenic contractions of the quiescent, oestrogen-dominated 
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Effects of graded concentrations of Harpagophytum procumbens secondary root aqueous 
extract (HPE) on oestrogen-dominated rat isolated uterine muscle strip. HPE 1, 2, 3, 4 
and 5 represent 25, 50, 100, 200 and 400 p,g/ml of Harpagophytum procumbens 
secondary root aqueous extract cumulatively added to the bath fluid at the solid points 
( • ) respectively. HPE was washed out at the open, downward-pointing, right-hand-side 
arrow. 
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800 
Dose-response curve to sequentially-administered concentrations of Harpagophytum 
procumbens secondary root aqueous extract (HPE, 10-800 Jlg/ml) on oestrogen-
dominated rat isolated uterine muscle strip. Each point (.) represents the mean (±SEM) 
of7-8 observations, while the vertical bars denote standard errors of the means. 
concentrations of Harpagophytum procumbens secondary root aqueous extract (HPE, 10-
1000 Ilg/ml) were reduced in a concentration-dependent manner by bath-applied 
indomethacin (IDM, 0.1-5.0 Ilg/ml) or atropine (AIR, 0.1-5.0 Ilg/ml). However, the 
plant's extract (HPE)-induced spontaneous, myogenic contractions of the quiescent, 
oestrogen-dominated uterine muscle strips were resistant to the actions of all other 
receptor specific antagonists used. Relatively low to moderate concentrations of the 
plant's extract (HPE, 10-800 Ilg/ml) potentiated ACh-, PHY-, BKN- and OTC-induced 
contractions of the oestrogen-dominated isolated uterine muscle strips in a concentration-
related manner. 
(ii) Pregnant uterine strips: 
Uterine muscle strips taken from pregnant rats were found to be spontaneously active, 
producing rhythmic contractions on their own accord. The pharmacological effects of 
HPE on isolated uterine muscle strips taken from pregnant rats were found to be 
qualitatively and quantitatively similar to those produced by the plant's extract on 
oestrogen-dominated isolated uterine muscle strips taken from stilboesterol-pretreated, 
non-pregnant female rats. Relatively low to high concentrations of Harpagophytum 
procumbens secondary root aqueous extract (HPE, 10-1000 Ilg/ml) provoked 
concentration-related, significant (P<O.OS-O.OOl) increases in the baseline tone (basal 
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tension) and contracted uterine muscle strips taken from rats in the early, middle or late 
stages of pregnancy. 
The possibility that the HPE-induced responses of the chick isolated oesophagus muscle 
strips and guinea-pig isolated ileum muscle preparations used in this study might involve 
interaction with Ca2+ at the cell membrane was investigated. The concentration of Ca2+ in 
the bathing Krebs-Henseleit solution was reduced from 0.26 g/litre to 0.13 g/litre, and 
raised from 0.26 g/litre to 0.52 g/litre respectively. The initial increases in baseline tones 
of the chick oesophagus and guinea-pig isolated ileum muscle preparations induced by 
relatively low concentrations of HPE (10-200 ).lg/ml) were abolished or reduced in the 
presence of low calcium concentration [Ca2+ = 0.13 g/litre] in the bathing Krebs-
Henseleit physiological solution. Similarly, the contractile responses of the isolated 
muscle strips induced by moderate to high concentrations of HPE (200-1000 ).lg/ml) 
decreased as the concentration of the external Ca2+ was reduced. Raising the bathing fluid 
Ca2+ concentration from 0.26 g/litre to 0.52 g/litre increased andlor enhanced low HPE 
(10-400 ).lg/ml) concentration-induced initial stimulant responses of the isolated muscle 
preparations. Similarly, the contractile responses of the isolated muscle strips induced by 
moderate to high concentrations of HPE (200-1000 ).lg/ml) were increased as the Ca2+ 
concentration of the external bathing fluid was increased. The secondary, longer-lasting 
inhibitory effects of moderate to high concentrations of the plant extract (HPE, 200-1000 
).lg/ml) on rabbit isolated duodenum increased with reduced calcium concentrations in the 
bathing fluid, and decreased when the external calcium concentration was increased. 
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In all cases, washing of the isolated muscle preparations with fresh, normal Krebs-
Henseleit physiological solution 3-5 times usually restored physiological activities of the 
isolated muscle strips to normal, control values. 
Anticholinesterase Determination 
The plant's extract (HPE, 10-1000 !J.g/ml) produced dose-related anticholinesterase 
activity in the colorimetric assay method used. However, the anticholinesterase activity 
of the plant's extract (HPE, 10-1000 !J.g/ml) was found to be far less than that of 
physostigmine (PHY, 0.01-10.0 !J.g/ml) - see Figure 11. In the colorimetric assay method 
used, the chick biventer-cervicis muscle homogenates gave better and more reproducible 































Anticholinesterase activity of Harpagophytum procumbens secondary root aqueous 
extract (HPE, .-.) compared with physostigmine (PRY, l1-li) on chick isolated 
biventer-cervicis muscle homogenates. HPE inhibited the chick cholinesterase enzyme in 
a concentration-related manner. In this regard, however, physostigmine (PRY) is far 
more potent than HPE. For both PRY and HPE, each point represents the mean (±SEM) 
of6-9 determinations, while the vertical bars denote standard errors of the means. 
DISCUSSION 
Relatively low to high doses of Harpagophytum procumbens root aqueous extract (HPE) 
produced dose-related, significant (P<O.05-0.001) increases in the basal tone of, and 
contracted, the chick isolated oesophagus and guinea-pig isolated ileum in a 
concentration-dependent manner. This observation is in consonance with the findings of 
Occhiuto et al., (1985). Bath-applied acetylcholine, physostigmine and indirect electrical 
stimulation of the chick oesophageal muscle preparations also induced contractions of the 
chick isolated muscle preparations in a concentration-dependent, and frequency-related 
manner respectively. Although the precise mechanism of the contractile action of the 
plant's extract on the muscle preparations used in the present study is obscure at present, 
it is speculated that (i) acetylcholine-like, direct stimulation and/or excitation of 
cholinergic muscarinic receptors, and (ii) inhibition of cholinesterase enzymes by the 
herb's extract, may have contributed significantly to the contractile effects of the plant's 
extract in the in vitro experimental animal models used in this study. 
The precise mechanism of the secondary, inhibitory effects of the plant's extract on rabbit 
isolated duodenum muscle preparations is also unknown at the moment. However, 
because the secondary inhibitory effects of the plant's extract (HPE) were resistant to 
blockade by standard, receptor specific antagonists in all the isolated muscle preparations 
tested, it is speculated that the secondary, longer-lasting inhibitory and/or depressant 
effects of HPE on the rabbit duodenal muscle preparations may be non-specific in nature. 
Furthermore, the finding that changes (decrease or increase) in calcium ion 
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concentrations of the bathing physiological solution modified the responses of the 
isolated tissue preparations to bath-applied concentrations of Harpagophytum 
procumbens root aqueous extract (HPE) would appear to suggest that HPE affects 
calcium mobilization and/or sequestration, and possibly also, calcium release from its 
various tissue stores. Further studies are certainly warranted to shed more light on this 
plausible mechanism of action of HPE. 
However, the experimental evidence obtained in the present laboratory animal study 
indicates that the plant's extract contracts gastro-intestinal tract smooth muscles. This 
observation would appear to provide pharmacological basis for the frequently reported 
adverse effect of 'gastro-intestinal tract discomfort or upset' commonly associated with 
Harpagophytum procumbens root extract medication. 
Relatively low to high concentrations of Harpagophytum procumbens secondary root 
aqueous extract (HPE) always induced concentration-related, significant (P<O.05-0.001), 
persistent and profound spontaneous, rhythmic, myogenic contractions of, and 
contracted, uterine muscle strips taken from stilboesterol-pretreated female rats. The 
plant's extract produced similar contractile effects on uterine muscle strips taken from 
pregnant rats. The precise mechanism of this stimulant action of the plant's extract on 
uterine muscle strips is not fully understood at the moment. However, the ability of 
indomethacin and/or atropine to reduce HPE-induced contractions of the uterine muscle 
preparations used in this study may be taken to suggest possible release of prostaglandins 
and/or other uterotonic substances or mediators, including acetylcholine, by the plant's 
extract. The observation that Harpagophytum procumbens secondary root aqueous 
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extract (HPE) possesses anticholinesterase activity would appear to buttress the possible 
involvement of cholinergic muscarinic receptor stimulation in the uterine stimulant, 
uterotonic action of HPE. 
Harpagophytum procumbens secondary roots have been reported to be rich in sugars, 
phytosterols, triterpenoids, coumarins, flavonoids and iridoids (Watt and Breyer-
Brandwijk, 1962; VanWyk and Gericke, 2000; VanWyk et al., 2002; VanWyk and 
Wink, 2004). Although only a few pharmacological studies on Harpagophytum 
procumbens secondary root extract have been reported in biomedical literature, the 
iridoids harpagoside (a cinnamic acid ester), harpagide and procumbide are speculated to 
have contributed significantly to the contractile effects of the plant's root extract on the 
isolated gastro-intestinal tract muscle preparations, and to the uterotonic action of the 
herb's extract on the uterine muscle strips. However, the experimental evidence obtained 
in the present in vitro study indicates that aqueous root extract of H procumbens 
possesses contractile action on gastro-intestinal smooth muscles, and uterotonic action on 
mammalian uterus. These findings appear to provide pharmacological rational for the 
'abdominal discomfort and/or upset' associated with Harpagophytum procumbens 
secondary root extract medication, and also suggest that the use of Harpagophytum 
procumbens root extract should be contra-indicated and avoided in pregnancy. The 
gastro-intestinal tract smooth muscle contractile effects and uterotonic action of the 
plant's extract (HPE) may be due, through the complex interactions that might occur 
among the various chemical constituents of the plant, to release of mediators and 
substances that are capable of contracting smooth muscles. However, the findings of this 
53 
study lend pharmacological credence to the suggested folkloric, obstetric uses of the 
plant's root extract for induction or acceleration of labour, as well as for expulsion of 




CARDIOV ASCULAR PHARMACOLOGY OF 
HARPAGOPHYTUM PROCUMBENS DC 
ABSTRACT 
In an attempt to scientifically appraise the 'healing powers' and medicinal value of 
Harpagophytum procumbens DC root aqueous extract (HPE), and throw some light on 
the efficacy and safety of the medicinal plant product, the cardiovascular effects of the 
herb's root aqueous extract (HPE) have been investigated in some mammalian 
experimental animal models. The results of this laboratory animal study indicate that 
relatively moderate to high doses of H procumbens root aqueous extract (HPE, 10-500 
mg/kg i. v.) produced dose-dependent hypotensive and cardio-depressant effects on 
systemic arterial blood pressures and heart rates of pentobarbitone-anaesthetized rats. 
Relatively low to high concentrations of the plant's extract (HPE, 10-1 000 ~g/ml) also 
produced concentration-related biphasic responses in isolated cardiac muscle strips of 
guinea-pigs and isolated portal veins of rats. Relatively low concentrations of the plant's 
extract (HPE, 10-1 00 ~g/ml) always produced initial slight, transient and non-significant 
(P>0.05) positive chronotropic responses in isolated spontaneously-beating right atria, 
but significant (P<0.05) positive inotropic responses in isolated electrically-driven left 
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atria of guinea-pigs. However, moderate to high concentrations of the plant's extract 
(HPE, 200-1000 Ilg/ml) always induced dose-dependent, significant (P<0.05-0.001), 
secondary longer-lasting, negative chronotropic and inotropic responses of the isolated 
spontaneously-beating right-, and isolated electrically-driven left-, atrial muscle 
preparations of guinea-pigs. The plant's extract also produced concentration-related 
biphasic effects on rat isolated portal vein. Low to high concentrations of the plant's 
extract (HPE, 10-1000 Ilg/ml) always produced dose-dependent, initial slight, transient 
and significant (P<0.05-0.001) contractions of the rat isolated portal veins, followed by 
secondary, longer-lasting, significant (P<0.05-0.001) relaxations of the muscle 
preparations. Although the precise mechanisms of the hypotensive and cardio-depressant 
actions of HPE are unknown, the vasorelaxant action of the plant's extract is speculated 
to contribute, at least in part, to the hypotensive action of the plant's extract. The results 
of this laboratory animal study lend pharmacological credence to the suggested folkloric 
uses of Harpagophytum procumbens root in the management and/or control of 
hypertension and certain cardiac disorders in some communities of South Africa. 
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INTRODUCTION 
Reports on cardiovascular pharmacology of Harpagophytum procumbens DC secondary 
root extracts are sparse in the literature. Circosta et ai., (1984) reported protective effects 
of crude methanolic extracts of the secondary roots of Harpagophytum procumbens DC 
in some experimental arrhythmias (induced by aconitine, calcium chloride, chloroform-
epinephrine) in rats and rabbits. Similarly, Costa De Pasquale et ai., (1985) have 
investigated the effects of pre-treating rats with crude methanolic extracts of 
Harpagophytum procumbens, and with harpagoside, on experimental model of 
hyperkinetic ventricular arrhythmias (HV A), using Langendorff preparations of rat heart. 
The latter investigators induced HV A in the Langendorff preparations of the rat hearts by 
ischaemic perfusion and reperfusion at basal conditions of 50 mmHg pressure and 8 
ml/min coronary flux. They observed that crude methanolic extracts of Harpagophytum 
procumbens DC secondary roots and harpagoside produced dose-dependent, significant, 
protective effects on HVA-induced reperfusion. Apart from these early works suggesting 
cardio-protective effects of Harpagophytum procumbens secondary root extracts in some 
experimental forms of arrhythmias, we are unaware of any other report on the 
cardiovascular pharmacology of Harpagophytum procumbens DC secondary roots 
extracts. 
In order to throw more light on the cardiovascular pharmacology of Harpagophytum 
procumbens DC secondary roots extracts, it was thought worthwhile examining the 
effects of the plant's aqueous extract on cardiovascular parameters that have not, to date, 
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been reported in the literature, using laboratory animal experimental models. In the 
experiments reported in this section of the thesis, the pharmacological effects of 
Harpagophytum procumbens DC secondary root aqueous extract have been investigated 
on: 
(i) rat isolated portal vein; 
(ii) guinea-pig isolated spontaneously-beating right atrial muscles; 
(iii) guinea-pig isolated electrically-driven left atrial muscles; 
(iv) systemic arterial blood pressure of rats. 
MATERIALS AND METHODS 
Plant Material 
The plant material used, its preparation and extraction are the same as those described in 
detail under Chapter Two of this Thesis. 
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Animal Material 
Young adult, Wi star rats (Rattus norvegicus) of both sexes weighing 250-300 g; and 
Dunkin-Hartley guinea-pigs (Cavia porcellus) weighing 300--450 g; were used. The 
animals were kept and maintained under laboratory conditions of temperature, humidity, 
and light; and were allowed free access to food and water ad libitum. 
Effects of Harpagophytum procumbens Root Aqueous Extract 
on Rat Systemic Arterial Blood Pressure and Heart Rate in vivo: 
Arterial blood pressures and heart rates of pentobarbitone-anaesthetized rats were 
measured directly from arterial catheters as described in detail by Ojewole (1976) and 
Bunag (1984). Pentobarbitone (60 mg/kg i. p.)-anaesthetized male and female, young 
adult Wi star rats weighing 300--400 g were used. The trachea of each rat was cannulated 
for artificial respiration, but the animal was still allowed to breathe spontaneously. When 
necessary, the animals were artificially ventilated with room air, using Palmer positive-
pressure ventilation pump (at a rate of 20/min., and stroke volume of 40-60 ml). The 
right femoral vein of each rat was cannulated for drug administration, and heparin (200 
unitslkg body weight) was administered intravenously. Additional small doses of the 
anaesthetic agent (pentobarbitone) were administered intravenously when necessary, 
during the course of the experiment. Arterial blood pressures (systolic, diastolic and mean 
60 
blood pressures) and limb lead II electrocardiogram (ECG) were recorded in the absence, 
and in the presence of HPE (and other drugs used) by means of an Elema-Schonander 
Mingograph. The electrocardiogram (ECG, limb lead II) and arterial blood pressures 
were monitored at a fast paper speed of 250 mmlmin. Systemic arterial blood pressure of 
each rat was recorded with a capacitance transducer (Elema-Schonander EMT 35) from a 
catheter inserted through the left carotid artery (lying in the aortic arch) of the animal. 
The Elema-Schonander differentiator was calibrated by measuring the slope of the 
upstroke of the pressure pulse, and both systolic and diastolic blood pressures (expressed 
in mmHg) were recorded. Mean arterial blood pressure was obtained by electronic 
integration. Heart rate was calculated by counting either the number of pulses from the 
arterial blood pressure, or the number of QRS-complex peaks from the ECG record, and 
expressed in beats/min. Doses ofHPE (and other drugs used) were injected intravenously 
into the animals through the femoral vein catheters in volumes not exceeding 0.3 ml, and 
washed in with 0.1 ml of distilled water, the vehicle in which HPE (and other drugs used) 
were dissolved. Distilled water was used as control. 
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Effects of Harpagophytum procumbens Root Aqueous Extract on Guinea-
Pig Isolated Cardiac Muscles 
(i) Spontaneously-beating isolated right atria of guinea-pigs 
Isolated, spontaneously-beating right atrial muscle strips of guinea-pigs were prepared 
and set-up under physiological conditions as described in detail earlier by Ojewole 
(1976). Male and female Dunkin-Hartley guinea-pigs weighing 300-450 g were used. 
Each of the animals was killed by applying a sharp blow to the back of its head and bled 
out. The animals' hearts were quickly excised and placed in Petri-dishes containing 
oxygenated Krebs-Henseleit physiological solution at room temperature. Intact right atria 
were carefully dissected out free from ventricular, left atrial and connective tissues, and 
avoiding damage to the pace-maker region. The isolated right atrial muscle strips were 
then suspended in 30-ml 'Ugo Basile Two-Chambered Organ Baths' (model 4050) 
containing Krebs-Henseleit physiological solution (of composition, in g/litre: NaCl, 6.92; 
KCI, 0.34; NaH2P04, 0.15; NaHC03, 2.1; MgCh, 0.11; CaCh, 0.26; and glucose, 1.00) 
maintained at 32±1°C and continuously aerated with carbogen (i. e., 5% carbon-dioxide + 
95% oxygen gas mixture). Two right atrial muscle preparations (one used as 'control' and 
the other one used as 'HPE- or drug-treated' preparation) were always set-up to allow for 
changes in the atrial muscle sensitivity. Each preparation was subjected to a resting 
tension of 0.75 g, and allowed to equilibrate for 30-45 minutes, or until when the 
spontaneous contractions of the atrial muscle were stable, before it was challenged with 
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HPE (and other drugs used). Doses of HPE (and other drugs used) were added to the 
bath-fluid either cumulatively or sequentially (non-cumulatively), and washed out three-
to-five times after the maximum responses of the tissues were attained. Concentrations of 
HPE (and other drugs used) were repeated where appropriate and/or possible, at regular 
intervals of 20-30 minutes after the last washing. The spontaneous amplitude and rate of 
contractions, as well as HPE- (and other drugs-) induced responses of the isolated atrial 
muscle preparations were recorded isometrically by means of U go Basile force-
displacement transducers, 2-Channel "Gemini" Recorder, and pen-recording 
micro dynamometers (model 7070). The rate of contractions of the atrial muscle strips in 
the absence, and in the presence, of HPE (and other drugs used) was estimated at a fast 
paper speed of300 mm per minute. 
(ii) Electrically-driven isolated left atria of guinea-pigs 
Isolated, electrically-driven left atrial muscle strips of guinea-pigs were prepared and set-
up under physiological conditions as described in detail earlier by Ojewole (1976). Male 
and female Dunkin-Hartley guinea-pigs weighing 300-450 g were used. Each of the 
animals was killed by applying a sharp blow to the back of its head and bled out. The 
animals' hearts were quickly excised and placed in Petri-dishes containing oxygenated 
Krebs-Henseleit physiological solution at room temperature. Intact left atria were 
carefully dissected out free from ventricular, right atrial and connective tissues. The left 
atrial muscle strips were then impaled on thin platinum wire electrodes and suspended in 
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30-ml 'Ugo Basile Two-Chambered Organ Baths' (model 4050) containing Krebs-
Henseleit physiological solution maintained at 32±1°C and continuously aerated with 
carbogen (i. e. , 5% carbon-dioxide + 95% oxygen gas mixture). Each left atrial muscle 
preparation was driven electrically with square wave pulses of 5 msec duration at a 
frequency of 3 Hz and with supramaximal voltage of 5-10 volts delivered from SRI 
stimulators. Two left atrial muscle preparations (one used as 'control' and the other one 
used as 'HPE- or drug-treated' preparation) were always set up to allow for changes in 
the atrial muscle sensitivity. The tissues were subjected to a resting tension of 0.75 g, and 
allowed to equlibrate for 30-45 minutes, or until when the force of contractions of the left 
atrial preparations were stable, before they were challenged with doses of HPE (or other 
drugs used). Doses of HPE (and other drugs used) were added to the bath fluid either 
cumulatively or sequentially (non-cumulatively), and washed out three-to-five times after 
the maximum responses of the tissues were attained. Concentrations of HPE (and other 
drugs used) were repeated where appropriate and/or possible, at regular intervals of 20-
30 minutes after the last washing. The electrically-induced contractions, as well as HPE-
(and other drugs-) induced responses of the isolated atrial muscle preparations were 
recorded isometrically by means of U go Basile force displacement transducers, 2-
Channel "Gemini" Recorder, and pen-recording microdynamometers (model 7070). The 
force of contractions of the atrial muscle strips in the absence, and in the presence, of 
HPE (and other drugs used) was estimated at a fast paper speed of 300 mm per minute. 
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Effects of Harpagophytum procumbens Root Aqueous Extract on Rat 
Isolated Portal Vein 
The experimental procedure used for the rat isolated portal vein was adopted from that 
described in detail earlier by Ojewole (1976). Wistar albino rats of both sexes weighing 
200-350 g were used. Each of the animals used was killed by deep petroleum ether 
inhalation and bled out. The abdomen of each animal was quickly opened by a midline 
incision, and the intestines were pulled to the left side of the animal. Portal veins with in 
situ lengths of approximately 20 mm were carefully cleaned free of connective, 
extraneous and fatty tissues, and then removed. The portal veins were separately 
suspended in 30-ml 'Ugo Basile Two-Chambered Organ Baths' (model 4050) containing 
Krebs-Henseleit physiological solution maintained at 36±1°C and continuously aerated 
with carbogen (i. e., 5% carbon-dioxide + 95% oxygen gas mixture). Two isolated portal 
vein preparations (one used as 'control' and the other one used as 'HPE- or drug-treated' 
preparation) were always set up to allow for changes in the venous muscle sensitivity. 
Each of the isolated venous muscle preparations was allowed to equilibrate for a period 
of 30-45 minutes under an applied resting tension of 0.5 g, before it was challenged with 
concentrations ofHPE (and other drugs used). Doses ofHPE (and other drugs used) were 
applied to the bath-fluid either cumulatively or sequentially (non-cumulatively), and 
washed out three-to-five times after the maximum responses of the tissues were attained. 
Concentrations of HPE (and other drugs used) were repeated where appropriate and/or 
possible, at regular intervals of 20-30 minutes after the last washing. The amplitude and 
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frequency (rate) of the spontaneous, myogenic contractions, as well as the HPE- (and 
other drug-) induced responses of the isolated portal veins were recorded isometrically 
with the aid of Ugo Basile force-displacement transducers, a 2-Channel "Gemini" 
Recorder, and pen-recording micro dynamometers (model 7070). The amplitude and 
frequency (rate) of contractions of the venous muscle strips in the absence, and in the 
presence, ofHPE (and other drugs used) were estimated at a fast paper speed of300 mm 
per minute. 
Preparations from Reserpinized Guinea-pigs and Rats 
Some of the experiments were carried out on isolated atrial muscle preparations and 
portal veins taken from guinea-pigs and rats pretreated with reserpine (5 mglkg i. p.) 18-
24 hours before use. Satisfactory reserpinization was confirmed by the absence of 
positive inotropic responses to bath-applied tyramine (2.5-1 0 ~g/ml). 
Data Analysis 
Data obtained from 'test' group of anaesthetized rats, guinea-pig isolated atrial muscle 
strips and rat portal vein preparations treated with Harpagophytum procumbens root 
aqueous extract (HPE) and other drugs used, as well as those obtained from distilled 
water-treated 'control' rats and isolated muscle preparations, were pooled, and expressed 
as means (±SEM). The difference between the plant extract (HPE)- or drug-treated 'test' 
means, and distilled water-treated 'control' means, was analyzed statistically. Where 
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appropriate, one-way analysis of variance (ANOVA), or the Student's t-test (Snedecor 
and Cochrane, 1967), was used to determine the level of significance of the difference 
between the 'test' and 'control' group data means. Values of P $ 0.05 were taken to 
imply statistical significance. 
RESULTS 
Rat Systemic Arterial Blood Pressure and Heart Rate in vivo 
Relatively moderate to high doses of Harpagophytum procumbens root aqueous extract 
(HPE, 10-500 mg/kg i. v.) produced dose-dependent and significant (P<0.05-0.001) 
reductions in the arterial blood pressures and heart rates of pentobarbitone-anaesthetized 
rats. Figure 12 shows a typical trace, while Table 1 summarizes the results obtained. The 
decreases in blood pressures and heart rates persisted for 5-60 minutes (depending on the 
dose administered), after which they gradually returned to baseline values. The cardio-
depressant effects of the plant's extract (HPE, 10-500 mg/kg i. v.) were not modified by 
18-24 hours pretreatment with atropine (1 .5 mg/kg i. p.) or mepyramine (8.0 mg/kg i. p.). 
At the same dose levels, HPE (10-500 mg/kg i. v.) depressed or abolished the rise in 
arterial blood pressures and heart rates of the anaesthetized rats induced by noradrenaline 
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Effects of Harpagophytum procumbens secondary root aqueous extract (HPE, 400 mg/kg 
i. v.) on the arterial blood pressure and heart rate (calculated from ECG limb lead II) of a 
pentobarbitone-anaesthetized rat. HPE (400 mg/ml) was administered intravenously into 
the rat at the left-hand-side solid (closed) upright arrow. 
\ . _ ; i 
Table 1. 
Cardiovascular effects ofHPE (50-400 mg/kg i.v.) in pentoobarbitone anaesthetized rats. 
Values given represent mean changes from controls (±SEM) 7-9 observations. 
Before 
HPE 
Cardiovascular parameter Control 
Systolic Blood Pressure 
(mm Hg) 120±7 
Diastolic Blood Pressure 
(mm Hg) 90±5 
Mean Blood Pressure 












Mean changes from control values 
HPE doses (mg/kg i. v.) 
100 200 400 
-32±5** -79±6*** -106±8*** 
-30±4** -68±5*** -85±7*** 
-25±5** -75±6*** -85±8*** 
-180±16* -240±15** -312±15*** 





dependently potentiated the depressor effects of acetylcholine (1 Ilg/kg i. v.) on the 
cardiovascular system of the anaesthetized rats used. 
Spontaneously-beating isolated right atria of guinea-pigs 
Relatively low to moderate concentrations of Harpagophytum procumbens root aqueous 
extract (HPE, 10-100 Ilg/ml) usually induced concentration-dependent, biphasic 
responses, consisting of an initial slight, transient, stimulant but non-significant (P>0.05) 
positive chronotropic responses, and significant (P<0.05- 0.01) increases in the amplitude 
of contractions of spontaneously-beating right atrial muscle strips. Relatively moderate to 
high concentrations of the plant's extract (HPE, 200-1000 Ilg/ml) always produced an 
initial transient but significant (P<0.05-0.001) increases in the amplitude of contraction, 
followed by secondary gradual, longer-lasting, significant (P<0.05-0.001) negative 
chronotropic responses. Figure 13 illustrates a typical trace, while Figure 14 summarizes 
the results obtained. The negative chronotropic effects of moderate to high concentrations 
of the plant's extract (HPE, 200-1000 Ilglml) were resistant to exogenous, bath-applied 
atropine (0.5-2.0 Ilg/ml). Pretreatment of the guinea-pigs with reserpine (5 mg/kg i. p.) 
for 18-24 hours, only partially inhibited HPE-induced initial transient stimulant, positive 
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Figure 13. 
Effects of graded concentrations of Harpagophytum procumbens secondary root aqueous 
extract on isolated, spontaneously-beating right atrial muscle strip of the guinea-pig. HPE 
1,2 and 3 represent 100, 200 and 400 ~g/ml of Harpagophytum procumbens secondary 
root aqueous extract cumulatively added to the bath-fluid at the solid, closed ce) dots 
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Figure 14. 
Effects of relatively high concentrations of Harpagophytum procumbens secondary root 
aqueous extract (HPE, ¢---¢ 400 and .-. 600 ~glml) on the rate (frequency) of 
contractions of isolated, spontaneously-beating right atrial muscle strips of guinea-pigs. 
Each point represents the mean (±SEM) of 6-8 observations, while the vertical bars 
denote standard errors of the means. 
Electrically-driven isolated left atria of guinea-pigs 
Relatively low to moderate concentrations of Harpagophytum procumbens root aqueous 
extract (HPE, 10-100 j.!g/ml) usually provoked concentration-related, transient, initial 
stimulant but significant (P<0.05-0.01) positive inotropic responses. However, relatively 
moderate to high concentration of the plant's extract (HPE, 200-1000 j.!g/ml) always 
produced biphasic effects, consisting of an initial very transient but significant (P<0.05-
0.01) positive inotropic response, followed by secondary gradual, longer-lasting, highly 
significant (P<0.01-0.001) negative inotropic responses. Figure 15 illustrates a typical 
trace, while Figure 16 summarizes the results obtained. The negative inotropic effects of 
moderate to high concentrations of the plant's extract (HPE, 200-1000 j.!g/ml) were 
resistant to exogenous, bath-applied atropine (0.5-2.0 j.!g/ml). Pretreatment of the guinea-
pigs with reserpine (5 mg/kg i. p.) for 18-24 hours, only partially inhibited HPE-induced 
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Effects of graded concentrations of Harpagophytum procumbens secondary root aqueous 
extract (HPE, 100-800 J.1g1ml) and distilled water (0.2 ml) on isolated, electrically-driven 
left atrial muscle strips of guinea-pigs. Graded concentrations of HPE (100-800 J.1g1ml) 
were cumulatively added to the bath-fluid at the (solid) closed (e) dots [in the 'drug-
treated' lower trace], while 0.2 m1 distilled water was also cumulatively added to the 
bath-fluid at the open (0) dots [in the 'control' upper trace]. HPE was washed out at the 
open, downward;pointing, right-hand-side arrow. 
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Figure 16. 
Effects of relatively moderate to high concentrations of Harpagophytum procumbens 
secondary root aqueous extract (HPE, 0-0 300, .-. 400 and v-v 600 /lglml) on 
isolated, electrically-driven left atrial muscle preparations of guinea-pigs. Each point 
represents the mean (±SEM) of 6-9 observations, while the vertical . bars represent 
standard errors of the means. 
Rat Isolated Portal Vein 
Relatively low to high concentrations of Harpagophytum procumbens root aqueous 
extract (HPE, 10-1000 Ilg/ml) always produced biphasic effects on rat isolated portal 
veins. The HPE-induced responses of the rat isolated portal veins always consisted of 
dose-related initial slight, transient stimulant but significant (P<0.05-0.0l) contractions 
of the venous muscle preparations, followed by secondary, longer-lasting, significant 
(P<0.05-0.001) relaxations of the muscle strips. During the initial transient, stimulant, 
contractile phase, the plant extract (HPE, 10-1000 Ilg/ml) usually increased the 
contractile frequency, and inhibited the amplitude of the spontaneous, myogenic 
contractions of the isolated portal vein in a concentration-dependent manner. Moderate to 
high concentrations of the plant's extract (HPE, 200-1000 Ilg/ml) always depressed or 
abolished the amplitude of the spontaneous, myogenic contractions of the portal veins, 
sharply contracted the muscle strips, and thereafter relaxed the muscle preparations in a 
concentration-related fashion. Figure 17 shows a typical trace, while Figure 18 
summarizes the results obtained. 
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Figure 17. 
Dual effects of a relatively high concentration of Harpagophytum procumbens secondary 
root aqueous extract (HPE, 800 Jlg/ml) on the amplitude (force) and frequency (rate) of 
spontaneous, myogenic contractions of the rat isolated portal vein. HPE (800 Jlglml) was 
added to the bath-fluid at the left-hand-side (solid) closed dot (.) and upright-pointing 
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Figure 18. 
Effects of relatively high concentrations of Harpagophytum procumbens secondary root 
aqueous extract-(HPE, ¢----¢ 400 and +-+ 600 Ilg/ml) on the amplitude (force) of 
contractions of rat isolated portal veins. Each point represents the mean (±SEM) of 6-8 
observations, while the vertical bars denote standard errors ofthe means. 
The possibility that the HPE-induced responses of the guinea-pig isolated atrial strips, 
and rat isolated portal vein muscle preparations used in this study might involve 
interaction with Ca2+ at the cell membrane was also investigated. The concentration of 
Ca2+ in the bathing Krebs-Henseleit solution was reduced from 0.26 gllitre to 0.13 g/litre, 
and raised from 0.26 gllitre to 0.52 g/litre respectively. The initial transient, stimulant 
responses of the isolated muscle strips induced by relatively low concentrations of HPE 
(10-100 Ilg/ml) were reduced and/or abolished in the presence of low calcium 
concentration [Ca2+ = 0.13 gllitre] in the bathing Krebs physiological solution. However, 
the secondary negative, inhibitory responses of the isolated muscle strips produced by 
moderate to high concentrations of HPE (200-1000 Ilg/ml) increased as the concentration 
of the external Ca2+ was reduced. Raising the bathing fluid Ca2+ concentration from 0.26 
gllitre to 0.52 g/litre increased and/or enhanced low HPE (l0-100 Ilglml) concentration-
induced initial transient, stimulant responses of the isolated muscle preparations. 
However, the secondary negative, inhibitory responses of the isolated muscle strips 
induced by moderate to high concentrations of HPE (200-1000 Ilglml) decreased as the 
Ca2+ concentration of the external bathing fluid was increased. 
In all cases, washing of the isolated cardiac and venous muscle preparations with fresh, 
normal Krebs-Henseleit physiological solution 3-5 times usually restored physiological 
activities of the isolated muscle strips to normal, control values. 
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DISCUSSION 
Relatively moderate to high doses of Harpagophytum procumbens root aqueous extract 
(HPE) produced dose-related, significant (P<0.05- 0.001) decreases in the arterial blood 
pressures and heart rates of pentobarbitone-anaesthetized rats. These observations are in 
agreement with the findings of Circosta et aI. , (1984), who reported that high doses of 
dried, crude methanolic extract of Harpagophytum procumbens secondary root caused 
dose-dependent, significant reductions in the arterial blood pressures of conscious, 
normotensive rats. With high doses of Harpagophytum procumbens dried root 
methanolic extract, Circosta et ai. , (1984) also observed concomitant decreases in the 
heart rates of conscious rats. In spontaneously-beating Langendorff preparations of rabbit 
hearts, Circosta et ai., (1984) found that Harpagophytum procumbens dried root crude 
methanolic extract caused mild decreases in the heart rate with concomitant mild positive 
inotropic effects at lower doses, but marked negative inotropic effects at higher doses. 
According to Circosta et aI. , (1984), the negative chronotropic and positive inotropic 
effects of harpagoside (the major constituent of Harpagophytum procumbens dried root 
extract) were comparatively higher with respect to that of the extract, whereas harpagide 
(another constituent of the plant's root extract) only had a slight negative chronotropic 
effect and a considerable negative inotropic effect. In the present study, however, the 
cardiac effects of harpagoside and harpagide were neither examined nor compared with 
those of the crude aqueous extract used. Hence, we are unable to comment appropriately 
on the latter findings of Circosta et al., (1984). It would appear, however, that both 
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harpagoside and harpagide contribute significantly to the inotropic and chronotropic 
effects of Harpagophytum procumbens dried root extract. Although the precise 
mechanism of the hypotensive action of the plant's extract is obscure at present, it is 
speculated that the vaso-relaxant action of the herb's extract may have contributed, at 
least in part, to its hypotensive effect in the mammalian experimental animals used. 
The results of the present study also strongly indicate that Harpagophytum procumbens 
root aqueous extract (HPE) possesses biphasic effects on isolated cardiac muscles of the 
guinea-pig and rat isolated portal vein. However, the initial transient stimulant effect of 
the plant's extract is likely to be partially due to its ability to release catecholamines from 
tissue stores, since the initial stimulant and/or positive chronotropic and positive inotropic 
responses of the atrial muscle strips to bath-applied low concentrations of the plant's 
extract were partially inhibited by 18-24 hours reserpine pretreatment. The precise 
mechanism of the secondary, cardio-depressant effect of the plant's extract on isolated 
cardiac muscle preparations is unknown at the moment. However, because the secondary 
cardio-depressant and venous relaxant effects of the plant's extract (HPE) were resistant 
to blockade by standard, receptor specific antagonists in all the isolated muscle 
preparations tested, it is speculated that the secondary, longer-lasting cardio-depressant 
and veno-relaxant effects of HPE on the muscle preparations may be non-specific in 
nature. Furthermore, the finding that changes (decrease or increase) in calcium ion 
concentrations of the bathing physiological solution modified the responses of the 
isolated tissue preparations used to bath-applied concentrations of Harpagophytum 
procumbens root aqueous extract (HPE), would appear to suggest that HPE affects 
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calcium mobilization and/or sequestration, and possibly also, calcium release from its 
various tissue stores. Further studies are certainly needed to shed more light on this 
plausible mechanism of action of HPE. 
Harpagophytum procumbens roots have been reported to be rich in sugars, phytosterols, 
triterpenoids, coumarins, flavonoids and iridoids (Watt and Breyer-Brandwijk, 1962; Van 
Wyk and Gericke, 2000; Van Wyk et ai., 2002; Van Wyk and Wink, 2004). Although 
only a few pharmacological studies on H procumbens root extract have been reported in 
the biomedical literature, the iridoids harpagoside (a cinnamic acid ester), harpagide and 
procumbide are speculated to contribute, at least in part, to the cardiovascular properties 
of the plant's root extract. 
The exact mechanisms of the hypotensive and cardio-depressant actions of H 
procumbens root aqueous extract are obscure at the moment. Similarly, the exact 
chemical compound/s responsible for the hypotensive and cardio-depressant effects of the 
plant's root aqueous extract in the experimental animal models used in this study still 
remainis speculative. However, the experimental evidence obtained in the present 
laboratory animal study lends pharmacological support to the suggested folkloric uses of 
the plant's root in the management and/or control of hypertension and certain 




NEUROPHARMACOLOGY OF HARPAGOPHYTUM 
PROCUMBENS DC 
A. EVALUATION OF ANALGESIC AND ANTI-
INFLAMMATORY ACTIVITIES: 
. ABSTRACT 
Harpagophytum procumbens DC is widely used in South African traditional medicine for 
the treatment, management andlor control of a variety of human ailments. In the present 
study, the analgesic effect of H procumbens secondary root aqueous extract was 
evaluated in mice, using the 'hot-plate' and 'acetic acid' test methods; while the anti-
inflammatory effects of the plant's root extract were investigated in rats. Fresh egg 
albumin-induced pedal oedema was used as experimental test model of inflammation. 
Morphine (MPN, 10 mg/kg i. p.) and diclofenac (DIC, 100 mg/kg i. p.) were used 
respectively as reference analgesic and anti-inflammatory agents for comparison. 
Harpagophytum procumbens secondary root aqueous extract (HPE, 50-800 mg/kg i. p.) 
produced dose-dependent, significant (P<0.05-0.001) analgesic effects against thermally-
84 
and chemically-induced nociceptive pain stimuli in mice. It is speculated that that the 
analgesic effects of the plant's root extract (HPE, 50-800 mg/kg i. p.) are centrally- and 
peripherally- mediated. Harpagophytum procumbens secondary root aqueous extract 
(HPE, 50-800 mg/kg i. p.) also produced dose-related, significant reductions (P<0.05-
0.001) in the fresh egg albumin-induced acute inflammation of the rat hind paw oedema. 
The results of this experimental animal study indicate that Harpagophytum procumbens 
secondary root aqueous extract possesses analgesic and anti-inflammatory properties. 
These observations lend pharmacological support to the suggested folkloric uses of 
Harpagophytum procumbens secondary root in the management and/or control of 
painful, arthritic and other inflammatory conditions in some communities of South 
Africa. 
INTRODUCTION 
The thick, fleshy, tuberous secondary tap roots of Harpagophytum procurnbens are 
usually dried and used in South African traditional medicine. In the form of infusions, 
decoctions, tinctures, powders and extracts, H procumbens is used for a variety of health 
conditions. In South Africa, the plant product has an ethnomedical reputation for efficacy 
in anorexia, indigestion, diabetes mellitus, hypertension, gout, fevers, skin cancer, 
infectious diseases (including tuberculosis), allergies, osteoarthritis, fibrositis and 
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rheumatism, being particularly effective in small joint diseases (VanWyk and Gericke, 
2000). Commercial ointments and creams of H procumbens are applied topically for 
minor muscular aches and pains, and to painful joints (Watt and Breyer-Brandwijk, 1962; 
Van Wyk and Gericke, 2000; Van Wyk et aI., 2002; Van Wyk and Wink, 2004). In an 
effort to scientifically appraise the 'healing powers' and medicinal value of 
Harpagophytum procumbens, the present study was designed to evaluate the analgesic 
and anti-inflammatory properties of the herb's secondary root aqueous extract in 
experimental models of pain and oedema. 
Literature abounds with contradictory reports on the analgesic and anti-inflammatory 
actions of Harpagophytum procumbens secondary root extracts. Several contemporary 
pharmacological studies in laboratory animals and man have supported the efficacy of 
Harpagophytum procumbens secondary root extracts in the management and control of 
painful, arthritic and other inflammatory conditions (Lanhers et al., 1992). The latter 
investigators concluded that the anti-inflammatory effects of the plant product are similar 
to, or greater than, those of potent non-steroidal anti-inflammatory agents (NSAIDs) such 
as phenylbutazone and indomethacin, and that its analgesic effects compared favourably 
to acetylsalicylic acid (aspirin). However, other pharmacological studies by some other 
researchers have indicated that Harpagophytum procumbens secondary root extracts have 
no or very little if any, anti-inflammatory, antirheumatic or analgesic activity (Grahame 
and Robinson, 1981; Whitehouse,1983; Moussard, 1992). The core aim of the present 
study was to substantiate or deny the efficacy of Harpagophytum procumbens secondary 
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root aqueous extract in experimental models of pain and inflammation, using mice and 
rats. 
MATERIALS AND METHODS 
Plant Material 
The plant material used in this set of experiments, its preparation and extraction, are the 
same as those described in detail under Chapters Two and Three of this Thesis. 
Animal Material 
Balb C albino mice (Mus domesticus) weighing 20-25 g, and young adult Wistar rats 
(Rattus norvegicus) weighing 250-300 g were used. The animals were kept and 
maintained under laboratory conditions of temperature, humidity, and light; and were 
allowed free access to food (standard pellet diet) and water ad libitum. The animals were 
divided into drug-treated 'test' and distilled water-treated 'control' groups of 8 animals 
per group. All the animals were fasted for 12 hours, but still allowed free access to water, 
before the commencement of our experiments. It has been shown that oral administration 
and subsequent passage of Harpagophytum procumbens root extract through the stomach 
(where the pH is acidic) leads to loss of pharmacological activity of the extract - due to 
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deactivation of its active constituents by gastric acid juices (Soulimani et al., 1994). In 
the present study, therefore, Harpagophytum procumbens root aqueous extract has been 
administered intraperitoneally, a route that ensures adequate systemic bioavailability and 
pharmacological activity of the extract. 
Evaluation of Analgesic Activity 
Balb C albino mice (Mus domesticus) weighing 20-25 g were used for the analgesic 
evaluation experiments. The 'hot-plate' (thermal) and 'acetic acid' (chemical) test 
methods were used. 
'Hot-Plate' Test Method: 
The 'hot-plate' (thermal) test method employed in this study was modified from those 
described in detail by Eddy and Leimback (1953), Lanhers et aI., (1992) and Williamson 
et al., (1996). A 600-ml glass beaker was placed on a 'Heidolph® MR 2002' hot-plate 
(with adjustable temperature). The temperature of the hot-plate was then regulated to 
45±1°C. Each mouse was placed in the glass beaker (on the hot-plate) in order to obtain 
the animal's response to electrical heat-induced nociceptive pain stimulus (licking of the 
forepaws and eventually jumping out of the glass beaker). Jumping out of the beaker was 
taken as an indicator of the animal's response to heat-induced nociceptive pain stimulus. 
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The time taken for each mouse to jump out of the beaker (i. e., reaction time) was noted 
and recorded in seconds. Each mouse served as its own control. Thus, before treatment, 
its reaction time was determined thrice at I-hour intervals. The mean of these three 
determinations constituted the 'initial reaction time' - that is, reaction time before 
treatment of the mouse. The mean reaction times for all the mice used were pooled to 
obtain the final, 'control' mean reaction time (Tb). Each of the test mice was thereafter 
treated with either distilled water, Harpagophytum procumbens root aqueous extract 
(HPE), or morphine (MPN). Twenty minutes after treatment with distilled water, the 
plant extract (HPE), or reference drug (MPN), the reaction time was again evaluated, but 
only once on this occasion. This value was pooled for the mice used in each treatment 
group, and the final 'test' mean value (Ta) for each treatment group was calculated. This 
final 'test' mean value represented 'after-treatment reaction time' (Ta) for each group of 
treated mice. This 'test' mean value (Ta) was subsequently used to determine percentage 
thermal pain stimulus relief or protection, by applying the formula: 
% protection against thermal pain stimulus Test Mean - Control Mean X lOOIControl Mean 
Ta- Tb X lOO/Tb 
The plant extract (HPE) was tested at doses of 50, 100, 200, 400 and 800 mglkg i. p. 
respectively. The reference drug, morphine (MPN), was used at a dose of 10 mglkg i. p. 
only. Treated 'control' mice received distilled water (2 mllkg i. p.) only. 
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'Acetic Acid' Test Method 
The 'acetic acid' test method used in this study was adopted from those described earlier 
by Koster et ai.,(1959); Williamson et ai. , (1996); Zakaria et aI., (2001) and Silva et 
al. ,(2003). The mice were divided into groups of ' test' and 'control' animals. There were 
two separate (A and B) groups of 'control' mice. Group A control mice were not pre-
treated with anything at all, and the 8 mice in this group (A) served as the 'untreated 
control' animals for all the mice in all the other groups. Each of these 'untreated Group 
A' mice was, however, treated with intraperitoneally administered 0.2 ml of a 3% acetic 
acid solution (Koster et ai. , 1959). Each mouse in the control group (B) was pre-treated 
with distilled water (2 ml/kg i. p.) only. In this test, dic10fenan (DIe, 100 mg/kg i. p.) 
was used as the reference analgesic drug for comparison. Each mouse in the treated 
'control' group (B), and in the other ' test' groups, was treated with either distilled water 
(2 ml/kg i. p.), dic10fenac (DIe, 100 mglkg i. p.), or a graded dose of Harpagophytum 
procumbens root aqueous extract (HPE, 50, 100, 200, 400 and 800 mglkg i. p.). Twenty 
minutes after pre-treatment with distilled water, reference drug (DIe), or a dose of the 
plant extract (HPE), 0.2 ml of a 3% acetic acid solution was injected intraperitoneally (i. 
p.) to each of the treated mice (Koster et aI. , 1959). The number of writhings (i. e., 
abdominal contractions and stretches) that occurred within the first 20 minutes following 
acetic acid administration were counted and recorded. The recorded numbers of acetic 
acid-induced writhings (abdominal contractions and stretches) that occurred in the HPE-, 
90 
DIC- and distilled water pre-treated mice were compared with those in the 'untreated 
Group A control' mice. 
Evaluation of Anti-inflammatory Activity 
Young adult Wistar rats (Rattus norvegicus) weighing 250-300 g were used. The animals 
were divided into three (A, B and C) groups of 8 rats per group. Group A rats were used 
as controls, and each of the animals in this group received distilled water (2 mllkg i. p.) 
only. Group B 'test' rats received Harpagophytum procumbens root aqueous extract 
(HPE, 800 mg/kg i. p.). Group C 'test' rats received diclofenac (DIC, 100 mg/kg i. p.). 
The rat hind paw oedema was used as a model of acute inflammation. Rat hind paw 
oedema was induced by intra-plantar injection of fresh egg albumin (0.5 ml/kg), a cheap 
phlogistic agent (Ekpendu et ai, 1994; Muko and Ohiri, 2000). Linear diameter of the 
injected paw was assessed for 3 hours at 30-minute intervals after the administration of 
the phlogistic agent. Increases in the linear diameter of the right hind paws were taken as 
an indication of paw oedema. Oedema was assessed in terms of the difference in the 'zero 
time' linear diameter of the injected right hind paw, and its linear diameter at 'time t' 
(i.e., 30, 60, 90, 120, 150 and 180 minutes) following fresh egg albumin administration. 
The increases in the right hind paw diameters (induced by injections of fresh egg 
albumin) were compared with those of the contra-lateral, non-injected left hind paw 
diameters (Hess and Milong, 1972; Oriowo, 1982; Ekpendu et at, 1994; Muko and Ohiri, 
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2000; Ojewole, 2003). Harpagophytum procumbens root aqueous extract (HPE) was 
separately administered at a dose of 800 mg/kg i. p. (a dose that was found to produce 
76% - 89% of the maximal anti-inflammatory effect of the crude water extract in our 
pilot experiments) to each of the rats in the 'test' Group B, 20 minutes before inducing 
inflammation with the injection of fresh egg albumin. Rats in the reference, comparative 
'test' Group C received diclofenac (DIC, 100 mg/kg p.o.); while rats in the 'control' 
Group A received distilled water (2ml/kg i. p.) only. 
Percentage inflammation (oedema) was calculated from the formula: Co/Ct X 100; while 
percent inhibition of the oedema was calculated from the formula: Co - CtlCo X 100 
[where Co is the average inflammation (hind paw oedema) of the 'control' Group A rats 
at a given time; and Ct is the average inflammation of the (Group B) plant extract- or 
(Group C) diclofenac-treated rats at the same time]. 
Data Analysis 
Data obtained were pooled and presented as means (±SEM). Data from 'control' mice 
and rats were used as baseline values. The differences between the plant's extract- or 
diclofenac-treated 'test' mice, and distilled water-treated 'control' animals, were analysed 
statistically. The data were subjected to paired "Student's t-test", and the level of 
significance of the differences between the 'test' and 'control' group data was 




Harpagophytum procumbens root aqueous extract (HPE, 50-800 mg/kg i. p.) produced 
dose-related, significant (P<0.05-0.001) analgesic effects against thermally- and 
chemically-induced nociceptive pain stimuli (see Tables 2 and 3). Pretreatment of the 
mice with the plant's extract (HPE, 50-800 mg/kg i. p.) caused significant (P<0.05-
0.001) delays in the reaction times of the animals to thermally-induced pain. Similarly, 
morphine (MPN, 10 mg/kg i. p.) profoundly delayed the reaction times of the animals 
(Table 2). Harpagophytum procumbens root aqueous extract (HPE, 50-800 mg/kg i. p.) 
caused dose-dependent, significant (P<0.05-0.00 1) reductions in the acetic acid-induced 
writhes of the mice. Similarly, diclofenac (DIe, 100 mglkg i. p.) profoundly inhibited 
acetic acid- induced writhes in the animals (Table 3). 
Anti-inflammatory Activity 
Subplantar injections of fresh egg albumin (0.5 ml/kg) produced profound and time-
related increases in the rat hind paw oedema of the 'control' rats. Plantar swelling and/or 
oedema (which became evident approximately 5-8 minutes following fresh egg albumin 
administration) reached its peak approximately 90 minutes after the fresh egg albumin 
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Table 2. 
Effects Harpagophytum procumbens root aqueous extract (HPE, 50-800 mglkg i. 
p.) and morphine (MPN, 10 mglkg i. p.) on electrical heat-induced pain stimulus. 
Each value represents the mean (±SEM) of 8 observations. 
GROUP DOSE Mean reaction time % Protection 
(i. p.) (seconds) 
Control Group A 
(untreated) 0 10.10+ 1.44 0.00 
Control Group B 
(distilled water treated) 2 ml/kg 10.15+1.45 0.50NS 
HPE 50 mg/kg 12.30+ 1.42* 21.78* 
HPE 100 mglkg 13.45+ 1.36* 33.17* 
HPE 200 mglkg 14.55+ 1.48** 44.06** 
HPE 400 mglkg 16.25+ 1.50* * 60.89** 
HPE 800 mg/kg 18.1 0+ 1.55*** 79.21 *** 
Morphine (MPN) 10 mglkg 20.12+2.10*** 99.21 *** 
NS = P > 0.05; *p < 0.05 ; **p < 0.01; ***p < 0.001 vs Control 
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Table 3. 
Effects of Harpagophytum procumbens root aqueous extract (HPE, 50-800 mg/kg 
i.p.) and diclofenac (DIC, 100 mg/kg i. p.) on acetic acid-induced pain stimulus. 
Each value represents the mean (±SEM) of 8 observations. 
GROUP DOSE Number of writhings % Inhibition 
(i. p.) (contractions) in 20 
min. 
Control Group A 
(untreated) 0 76.48+8.24 0.00 
Control Group B 
(distilled water 2 ml/kg 75.84±8.25 0.84 NS 
treated) 
HPE 50 mg/kg 58.48+7.72* 23.54* 
HPE 100 mg/kg 42.40+7.56** 44.56** 
HPE 200 mg/kg 36.44+6.80** 52.35** 
HPE 400 mg/kg 29.96+6.64** 60.83** 
HPE 800 mg/kg 22.72+6.60*** 70.29** * 
Diclofenac (DIC) 100 mg/kg 8.42+6.34*** 88.99*** 
NS = P > 0.05 ; *p < 0.05; **p < 0.01 ; ***p < 0.001 vs Control 
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Table 4. 
Effects of Harpagophytum procumbens root aqueous extract (HPE, 400 and 800 mglkg i. p.) and diclofenac (DIC, 100 mg/kg i. p.) on 
fresh egg albumin-induced rat paw oedema (inflammation ). Each value represents the mean (±SEM) of 8 observations. Percentage 
inhibitions of the fresh egg albumin-induced inflammation (oedema) produced by HPE and DIe are indicated as (%). 
Treatment Dose Time (in minutes) diameter (in mm) 
(i. p.) 
30 60 90 120 150 180 
Control Group A 
0 1O.45±0.04 12.50±0.05 15.65±0.06 14.75±O.07 12.61±0.05 11.35±0.04 
( untreated) 
Control Group B 
2 ml/kg 10.50±0.05 12.46±0.07 15.66±0.09 14.80±O.06 12.60±0.08 11.38±0.05 
(distilled water 
treated) 
HPE 400 mg/kg 8.15±0.06* 7.56±0.04* 6.35±0.07** 5.40±0.09** 4.25±0.05*** 3.50±0.06*** 
(22.01%) (39.52%) (59.42%) (63.39%) (66.30%) (69.16%) 
HPE 800 mglkg 5.20±0.05** 4.70±0.05** 3.68±0.03*** 2.55±0.04*** 1.60±0.06*** 1.01±0.05*** 
(50.24%) (62.40%) (76.49%) (82.71%) (87.31%) (91.10%) 
Diclofenac (DIC) 100 mglkg 4.10±0.04** 3.61±0.06*** 2.75±0.05*** 1.32±0.06*** 0.40±0.03*** O.OO±OO*** 
(60.77%) (71.12%) (82.43%) (91.05%) (96.83%) (100%) 
----
* p < 0.05; **p < 0.01; ***p < 0.001 vs control 
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administration. Like diclofenac (DIC, 100 mg/kg i. p.), Harpagophytum procumbens 
root aqueous extract (HPE, 50-800 mg/kg i. p.) produced dose-related, profound and 
significant reductions (P<0.05-0.001) in the fresh egg albumin-induced acute 
inflammation of the rat hind paw (Table 4). However, the anti-inflammatory effect of 
the plant' s extract (HPE, 800 mg/kg i. p.) was found to be less than that of diclofenac 
(DIC, 100 mg/kg i. p.). Distilled water (2 mVkg i. p.) alone did not significantly 
(P>0.05) modify the fresh egg albumin-induced rat paw oedema. 
DISCUSSION 
Over the past four decades, many investigators have conducted studies m 
experimental animals and man, to validate scientifically, the effectiveness of 
Harpagophytum procumbens root extract (and its iridoid glycoside, harpagoside), as 
an analgesic, anti-inflammatory and anti-rheumatic agent. Results of these studies 
have been conflicting, with some researchers reporting positive effects (Lan hers, et 
al. ,1992), and other investigators reporting negative effects (Seeger, 1973; Grahame 
and Robinson, 1981 ; Whitehouse, 1983). However, the results of the present 
laboratory animal study indicate that aqueous root extract of Harpagophytum 
procumbens possesses analgesic and anti-inflammatory effects in the mammalian 
experimental animal models used. 
It has been reported that oral administration and subsequent passage of 
Harpagophytum procumbens root extract through the stomach (where the pH is 
acidic) leads to loss of pharmacological activity of the plant ' s extract - due to 
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deactivation of its active constituents by gastric acid juices (Soulimani, et ai., 1994). 
In the present study, therefore, the root aqueous extract of Harpagophytum 
procumbens used has been administered intraperitoneally, a route that ensures high 
systemic bioavailability and adequate pharmacological activity of the extract. 
Experimental evidence obtained in the present study show that Harpagophytum 
procumbens secondary root extract (HPE, 50-800 mg/kg i. p.) dose-dependently and 
significantly (P<0.05-0.001) delayed the reaction times of the mice used in the 'hot-
plate' analgesic test method. In the same 'hot-plate' test method, morphine (MPN, 10 
mg/kg i. p.) also profoundly delayed the reaction times of the animals. Moreover, the 
plant's extract (HPE, 50 - 800 mg/kg i. p.) significantly (P<0.05-O.001) inhibited 
acetic acid-induced writhes in mice. Similarly, diclofenac (DIe, 100 mg/kg i. p.) 
markedly reduced acetic acid-induced writhes in the mice. These observations suggest 
that Harpagophytum procumbens secondary root aqueous extract (HPE) probably 
possesses centrally- and peripherally-mediated analgesic properties. This hypothesis 
is in keeping with those of Eddy and Leimback (1953), Koster et ai., (1959) and 
Williamson et ai., (1996) who postulated that acetic acid-induced writhing and hot-
plate test methods are useful and appropriate models for the evaluation of 
peripherally- and centrally- acting analgesic drugs respectively. 
Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), is commonly employed 
in the treatment and/or management of rheumatoid arthritis, osteo-arthritis and 
ankylosing spondylitis (Siraux, 1977; Sigmeth and Sieberer, 1980; Brooks et ai., 
1980) for its anti-inflammatory and analgesic effects (Small, 1989). Diclofenac 
reduces inflammation, swelling and arthritic pain by inhibiting prostaglandins 
synthesis and/or production (Skoutakis et ai., 1988; Mahgoub, 2002). The drug also 
98 
affects polymorphonuclear leukocytes function in vitro, thereby reducing chemotaxis, 
superoxide toxic radical formation, oxygen-derived free radical generation, and 
neutral protease production (Freeman et al., 1986; Mahgoub, 2002). Diclofenac has 
also been reported to suppress inflammation induced by various phlogistic agents in 
experimental animal models (Menasse et al., 1978; AI-Tuwaijri and Mustafa, 1992; 
Mahgoub, 2002). The results of the present study tend to suggest that, like diclofenac, 
Harpagophytum procumbens root aqueous extract probably produces its analgesic and 
anti-inflammatory effects by inhibiting the release, synthesis and/or production of 
inflammatory mediators, including histamine, polypeptide kinins and prostaglandins. 
Harpagophytum procumbens roots have been reported to contain sugars, flavonoids, 
iridoid glycosides, phenolic acids, quinones, phytosterols, triterpenoids, acetoside 
esters and minerals (Watt and Breyer-Brandwijk, 1962; Van Wyk and Gericke, 2000; 
Van Wyk et aI., 2002). Although the exact chemical constituentls of H procumbens 
roots that is/are responsible for the observed analgesic and anti-inflammatory effects 
of the plant's aqueous extract still remains speculative, a number of investigators have 
shown that a host of secondary plant metabolites with diverse chemical structures 
possess analgesic, anti-inflammatory and hypoglycaemic effects in various 
experimental animal models (Dongmo et aI., 2003; Taesotiku et aI., 2003; Ojewole, 
2002; 2003; Adzu et al., 2003; Akah and Okafor, 1992; Maries and Farnsworth, 
1995). Since the secondary roots of Harpagophytum procumbens are known to 
contain triterpenoids, flavonoids and iridoids in addition to other chemical 
constituents, it is not unlikely that these chemical compounds might have contributed 
to the observed analgesic and anti-inflammatory effects of the plant's root extract. 
Several investigators have also attributed the anti-inflammatory (and hypoglycaemic) 
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properties of a number of plants to their triterpenoid, coumarm and flavonoid 
constituents (Gupta et al. , 1969; Singh et al., 1992; Liu, 1995; MarIes and 
Farnsworth, 1995; Ojewole, 2002; 2003). 
Experimental evidence obtained in the present laboratory animal study indicates that 
aqueous root extract of H procumbens possesses analgesic and anti-inflammatory 
properties. These pharmacological effects may be due to complex interactions among 
the various chemical constituents of the plant. However, the findings of the present 
study lend pharmacological support to the suggested folkloric uses of the plant's root 
in the management and/or control of painful, arthritic and other inflammatory 
conditions in some communities of South Africa. 
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B. EVALUATION OF ANTICONVULSANT 
ACTIVITY 
ABSTRACT 
Harpagophytum procumbens DC is widely used in South African traditional medicine 
for the treatment, management and/or control of a plethora of human ailments 
including febrile, childhood convulsions. In the present study, the anticonvulsant 
activity of Harpagophytum procumbens secondary root aqueous extract (HPE, 50-
800 mg/kg i. p.) has been examined against pentylenetetrazole (PTZ)-, picrotoxin 
(PCT)- and bicuculline (BCL)-induced seizures in mice. Phenobarbitone and 
diazepam were used as reference, standard anticonvulsant drugs for comparison. Like 
the standard anticonvulsant agents used, Harpagophytum procumbens secondary root 
aqueous extract (HPE, 100-800 mg/kg i. p.) significantly (P<0.05-0.001) delayed the 
onset of, and antagonized, pentylenetetrazole (PTZ)-induced seizures. The plant's 
extract (HPE, 100-800 mg/kg i. p.) profoundly antagonized picrotoxin (PCT)-induced 
seizures, but only partially and.; 'XeAkJy .,a~tagonized bicuculline (BCL)-induced 
~:.' (j Ll ~ ) ,fJ i..i ( l 
seizures. It is speculated that Harpagophytum procumbens secondary root aqueous 
extract (HPE) may be producing its anticonvulsant activity by enhancing GABAergic 
neurotransmission and/or facilitating GABAergic action in the brain. However, the 
results of this experimental animal study indicate that H procumbens secondary root 
101 
aqueous extract possesses anticonvulsant activity, and thus lend pharmacological 
support to the suggested folkloric uses of the plant extract in the management and/or 
control of epilepsy and childhood convulsions in some communities of South Africa. 
INTRODUCTION 
Harpagophytum procumbens DC, locally known as "Devil's claw, Grapple plant, 
Wood spider or Harpago", is widely used in South African traditional medicine for 
the treatment, management and/or control of an array of human ailments, including 
febrile childhood convulsions. Some traditional health practitioners in KwaZulu-Natal 
province of South Africa have claimed that Harpagophytum procumbens secondary 
root extract is a useful remedy in the management and/or control of epilepsy and 
childhood convulsions. However, there is no record or report whatsoever in the 
literature on the anticonvulsant activity of Harpagophytum procumbens secondary 
root extract. In an effort to scientifically appraise the 'healing powers' and medicinal 
value of Harpagophytum procumbens secondary root extract in epilepsy and/or 
convulsion, the present study was undertaken to examine the anticonvulsant activity 
of H procumbens secondary root aqueous extract in mice. 
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MATERIALS AND METHODS 
Plant Material 
The plant material used in this study, its preparation and extraction, are the same as 
those described in detail under Chapters Two and Three of this Thesis. 
Animal Material 
Balb C male albino mice (Mus domesticus) weighing 20-25 g were used. The animals 
were kept and maintained under laboratory conditions of temperature, humidity, and 
light; and were allowed free access to food (standard pellet diet) and water ad libitum . 
The animals were divided into drug-treated ' test' and distilled water-treated ' control' 
groups of 10 animals per group. All the animals were fasted for 12 hours, but still 
allowed free access to water, before the commencement of our experiments. 
It has been shown that oral administration and subsequent passage of Harpagophytum 
procumbens root extract through the stomach (where the pH is acidic) leads to loss of 
pharmacological activity of the extract - due to deactivation of its active constituents 
by gastric acid juices (Soulimani et aI., 1994). In the present study, therefore, H. 
procumbens root extract has been administered intraperitoneally (i. p.), a route that 
ensures adequate systemic bioavailability and pharmacological activity ofthe extract. 
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Evaluation of Anticonvulsant Activity 
Balb C male albino mice (Mus domesticus) weighing 20-25 g were used. The 
anticonvulsant testing method of Vellucci and Webster (1984) modified by 
Amabeoku and Chikuni (1993) was used to assess the anticonvulsant activity of the 
plant's extract (HPE) in the mice. Standard convulsant agents, pentylenetetrazole 
(PTZ, 90 mglkg i. p.) picrotoxin (PCT, 10 mglkg i. p) and bicuculline (BCL, 30 
mg/kg i. p.) were used to induce convulsions in the mice. Phenobarbitone (PBT, 20 
mg/kg i. p.) and diazepam (DZP, 0.5 mg/kg i. p.) were used as reference, standard 
anticonvulsant drugs for comparison. Following induction of convulsions in the 'test' 
mice (with intraperitoneal injections of the convulsant agents), the animals were 
observed for 30 minutes for signs of neurological deficits, especially, hind-limb tonic 
seizures or convulsions. Hind-limb tonic extensions of the mice were regarded as 
manifestations of seizures. The ability of the plant's extract (HPE, 50-800 mglkg i. 
p.) to prevent the seizures or delay/prolong the latency or onset of the hind-limb tonic 
extensions was considered as an indication of anticonvulsant activity (Navarro-Ruiz et 
al., 1995; Amabeoku et al., 1998). The experimental procedures were repeated with 
other groups of 'test' mice pretreated for 20 minutes with graded doses of the plant's 
extract (HPE, 50-800 mg/kg i. p.) or with the standard anticonvulsant drugs used for 
comparison - [i. e., phenobarbitone (PBT, 20 mglkg i. p.) and diazepam (DZP, 0.5 
mg/kg i. p.)], before the administrations of the convulsant agents. Because the plant 
extract and other drugs used in this study were dissolved in distilled water each day at 
the beginning of our experiments, distilled water (2 ml/kg i. p.) pretreated mice were 
used as 'control' animals. 
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Data Analysis 
Data obtained were pooled and presented as means (±SEM). Data from distilled-water 
(2 ml/kg i. p.) treated 'control' mice were used as baseline values. The differences 
between the plant extract-, and other drug-treated 'test' mice, and distilled water-
treated 'control' animals, were analysed statistically using paired 'Student's t-test' . 
The level of significance of the differences between the 'test' and 'control' group data 
was determined. The proportion of mice convulsing was analysed by 'Chi-Square 
test' (Bienvenu et aI., 2002). In all cases, values of P ~ 0.05 were taken to imply 
statistical significance. 
RESULTS 
Effect of Harpagophytum procumbens root aqueous extract (HPE) on 
pentylenetetrazole (PTZ)-induced seizures 
Pentylenetetrazole (PTZ, 90 mg/kg i. p.) produced hind-limb tonic seizures in all the 
ten mice used. Harpagophytum procumbens root aqueous extract (HPE, 100-800 
mglkg i. p.) produced dose-related, significant (P<0.05-0.001) protection of the mice 




Effects of Harpagophytum procumbens root aqueous extract (HPE), phenobarbitone (PBT) and diazepam (DZP) on pentylenetetrazole (PTZ)-induced 
seizures in mice. 
Treatment Dose (mg/kg i. p.) No. convulsed! % Animals not convulsed Latency of tonic 
PTZ HPE Phenobarbitone Diazepam No. used (i.e., % animals protected) convulsion (min) 
[Mean (±SEM] 
90 10/10 0 7.30 ± 0.50 
90 100 7/10 30 10.20* ± 1.45 
90 200 6/10 40 12.40* ±2.30 
90 400 5/10 50 15.50** ±2.25 
90 800 3110 70 19.36*** ± 2.30 
90 20 O/lOc 100 0.00*** 
90 0.5 0/10c 100 0.00*** 
*P<0.05; **P<O.OI; ***P<O.OOI vs pentylenetetrazole control (PTZ, 90 mg/kg i. p.); Paired Student's t-test. 
cp<O.OOI vs pentylenetetrazole control (PTZ, 90 mg/kg i. p.); Chi-Square test. 
106 
delayed (P<O.OS-O.OOl) the onset of, and antagonized, PTZ-induced seizures. The 
standard anticonvulsant drugs used, phenobarbitone (PBT, 20 mg/kg i. p.) and 
diazepam (DZP, O.S mg/kg i. p.) also profoundly delayed the onset of, and 
significantly antagonized (P<O.OOl), PTZ-induced seizures (Table S). 
Effect of Harpagophytum procumbens root aqueous extract (HPE) on 
picrotoxin (PCT)-induced seizures 
Picrotoxin (peT, 10 mg/kg i. p.) produced hind-limb tonic seizures in all the ten mice 
used. Harpagophytum procumbens root aqueous extract (HPE, 100-800 mg/kg i. p.) 
produced dose-related, significant (P<O.OS-O.OOl) protection of the mice against 
PeT-induced seizures (as in the PTZ-induced tonic seizures) - see Table 6. 
Furthermore, the plant's extract (HPE, 100-800 mg/kg i. p.) significantly delayed 
(P<O.OS-O.OOI) the onset of peT-induced seizures (as in the PTZ-induced tonic 
seizures). The standard anticonvulsant drugs used, phenobarbitone (PBT, 20 mg/kg i. 
p.) and diazepam (DZP, O.S mg/kg i. p.) profoundly delayed the onset of, and 
significantly antagonized (P<O.OOI), PeT-induced seizures (Table 6). 
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Table 6. 
Effects of Harpagophytum procumbens root aqueous extract (HPE), phenobarbitone (PBT) and diazepam (DZP) on picrotoxin (PCT)-induced 
seizures in mice. 
Treatment Dose (mglkg i. p.) No. convulsed! % Animals not convulsed Latency of tonic 
PCT HPE Phenobarbitone Diazepam No. used (i.e., % animals protected) convulsion (min) 
[Mean (±SEM] 
10 10/10 0 1O.20±0.58 
10 100 7/10 30 12.45* ± 1.30 
10 200 6/10 40 15.50* ±2.S0 
10 400 SIlO 50 17.55** ±2.1O 
10 800 3/10 70 20.46*** ± 2.30 
10 20 2/10
c 80 27.54*** 
10 0.5 1I10
c 90 28.10*** 
*P<O.OS; **P<O.Ol; ***P<O.OOl vs picrotoxin control (PCT, 10 mg/kg i. p.); Paired Student's t-test. 
cp<O.OOl vs picrotoxin control (PTZ, 10 mg/kg i. p.); Chi-Square test. 
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Effect of Harpagophytum procumbens root aqueous extract (HPE) on 
bicuculline (BCL)-induced seizures 
Bicuculline (BCL, 30 mg/kg i. p.) produced hind-limb seizures in all the ten mice 
used. Harpagophytum procumbens root aqueous extract (HPE, 200-800 mg/kg i. p.) 
produced dose-related, significant (P<0.05-0.01) protection of the mice against BCL-
induced seizures (Table 7). However, relatively low dose of the plant's extract (HPE, 
50-100 mg/kg i. p.) did not significantly alter (P>0.05) the onset of BCL-induced 
seizures, whereas, relatively moderate to high doses of the plant's extract (HPE, 200-
800 mg/kg i. p.) significantly delayed (P<0.05-0.0l) the onset of BCL-induced 
seizures. The two standard anticonvulsant drugs used, phenobarbitone (PBT, 20 
mg/kg i. p.) and diazepam (DZP, 0.5 mg/kg i. p.), profoundly antagonized, and 
significantly delayed (P<O.OOl) the onset of, BCL-induced seizures (Table 7). 
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Table 7. 
Effects of Harpagophytum procumbens root aqueous extract (HPE), phenobarbitone (PBT) and diazepam (DZP) on bicuculline (BCL)-induced 
seizures in mice. 
Treatment Dose (mglkg i. p.) No. convulsed! % Animals not convulsed Latency of tonic 
BCL HPE Phenobarbitone Diazepam No. used (i.e., % animals protected) convulsion (min) 
[Mean (±SEM] 
30 10/10 0 6.40±0.56 
30 100 8/10 20 8.10±1.40 
30 200 7110 30 9.50* ±2.20 
30 400 6/10 40 11.55** ±2.45 
30 800 SilO 50 13.46** ± 2.30 
30 20 0110
c 100 0.00*** 
30 0.5 0110
c 100 0.00*** 
*P<0.05; **P<O.Ol; ***P<O.OOI vs bicuculline control (BCL, 30 mg/kg i. p.); Paired Student's t-test. 




Although Harpagophytum procumbens secondary root extract is widely used by the 
traditional health practitioners of southern Africa for a variety of human ailments, 
little or no scientific information exists in biomedical literature on the therapeutic 
efficacy of the plant product. It has been reported that oral administration and 
subsequent passage of Harpagophytum procumbens root extract through the stomach 
(where the pH is acidic) leads to loss of pharmacological activity of the plant's extract 
- due to deactivation of its active constituents by gastric acid juices (Soulimani, et aI. , 
1994). This is an interesting observation, especially because the plant product is 
always administered orally to patients! However, in the present study, 
Harpagophytum procumbens secondary root aqueous extract has been administered 
intraperitoneally, a route that ensures high systemic bioavailability and adequate 
pharmacological activity ofthe extract. 
The results of the present laboratory animal study show that aqueous root extract of 
Harpagophytum procumbens (HPE) possesses anticonvulsant activity in the 
experimental animal model used. The data obtained in this study also indicate that 
relatively moderate to high doses of Harpagophytum procumbens secondary root 
aqueous extract (HPE) inhibited or attenuated pentylenetetrazole (PTZ)-induced 
seizures, while the standard anticonvulsant drugs used, phenobarbitone (PBT) and 
diazepam (DZP) , completely abolished the seizures and protected all the animals 
against PTZ-induced seizures. Pentylenetetrazole (PTZ) has been reported to produce 
seizures by inhibiting gamma-aminobutyric acid (GAB A) neurotransmission (Okada 
et al., 1989; De Sarro et al. , 1999). GABA is the main inhibitory neurotransmitter 
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substance in the brain, and is widely implicated in epilepsy. Enhancement of 
GABAergic neurotransmission has been shown to inhibit or attenuate seizures, while 
inhibition of GABAergic neurotransmission or activity is known to promote and 
facilitate seizures (Meldrum, 1975; Olsen, 1981; Gale, 1992; Leonard, 2000). It would 
appear, therefore, that the complete protection of the mice by the standard 
anticonvulsant drugs used in this study against PTZ-induced seizures is in keeping 
with the above hypothesis, since the standard anticonvulsant drugs used are known to 
exert their anticonvulsant actions by enhancing GABAergic neurotransmission and 
activity (Olsen, 1981; Leonard, 2000, Rang et al., 2000). The findings of the present 
study, therefore, tend to suggest that Harpagophytum procumbens secondary root 
aqueous extract (HPE) might have inhibited and/or attenuated PTZ-induced seizures 
of the mice by enhancing, or in some ways interfering with, GABAergic 
neurotransmission. 
The standard anticonvulsant drugs used in the present study, phenobarbitone (PBT) 
and diazepam (DZP), as well as Harpagophytum procumbens secondary root aqueous 
extract (HPE), profoundly antagonized picrotoxin (PCT)-induced seizures. 
Postsynaptic GABAA-receptors are functionally linked to benzodiazepine receptors, 
barbiturate receptors and chloride-ion channels to form GABA-chloride ionophore 
complex, which is intimately involved in the modulation of GABAergic 
neurotransmission (Olsen, 1981; Rang et al., 2000; Bennett and Brown, 2003). 
According to Nicoll (2001), picrotoxin, a GABAA-receptor antagonist, produces 
seizures by blocking the chloride-ion channels linked to GABAA-receptors, thus 
preventing the entry of chloride ions into the brain. This process will, in turn, inhibit 
GABA neurotransmission and activity in the brain (Nicoll, 2001). Phenobarbitone and 
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diazepam are believed to enhance GABAergic neurotransmission by increasing 
chloride ion flux through the chloride-i~m channels at GABAA-receptor sites (Olsen, 
1981; Rang et al., 2000). This hypothesis may explain the observed protective effects, 
and/or antagonistic actions of, phenobarbitone and diazepam (a benzodiazepine) 
against picrotoxin (PCT)-induced seizures in the mice used. Since Harpagophytum 
procumbens secondary root aqueous extract (HPE) mimicked, to a large extent, the 
anticonvulsant actions of the standard anticonvulsant dugs used in this study, it is not 
unlikely that the plant's extract (HPE) antagonizes picrotoxin (PCT)-induced seizures 
by opening the chloride-ion channels associated with GABAA-receptors. This 
proposal further buttresses the hypothesis that HPE may be interfering with 
GABAergic neurotransmission in one way or another. 
Bicuculline (BCL), a potent, selective GABAA-receptor antagonist, produces seizures 
by blocking the effect of GAB A at central GABAA -receptors, which have been 
associated with epilepsy (Gale, 1992; Rang et al., 2000). Phenobarbitone and 
diazepam, which act by enhancing GABA neurotransmission, antagonized bicuculline 
(BCL)-induced seizures in the present study. However, H. procumbens secondary root 
aqueous extract (HPE) only partially and weakly antagonized BCL-induced seizures, 
and was much less effective in this regard compared with phenobarbitone and 
diazepam. This observation also tends to suggest that HPE interferes with GABAergic 
neurotransmission but probably not through GABAA-receptor sites. Harpagophytum 
procumbens secondary roots have been reported to contain sugars, iridoid glycosides, 
flavonoids, phenolic acids, quinones, phytosterols, triterpenoids, acetoside esters and 
minerals (Watt & Breyer-Brandwijk, 1962; Van Wyk and Gericke, 2000; Van Wyk et 
aI., 2002). Although only a few pharmacological studies on H. procumbens have 
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been reported in the biomedical literature, the iridoids harpagoside (a cinnamic acid 
ester), harpagide and procumbide are speculated to account for the observed 
anticonvulsant activity of the plant's extract (HPE). However, the experimental 
evidence obtained in the present laboratory animal study indicates that aqueous root 
extract of H procumbens (HPE) significantly delayed the onset of seizures induced 
by pentylenetetrazole (PTZ) and also significantly antagonized picrotoxin (PCT)-
induced seizures. Since PTZ- and PCT-induced seizures have been shown to be due to 
inhibition and/or attenuation of GABAergic neurotransmission, it is reasonable to 
speculate that HPE probably produces its anticonvulsant activity by enhancing 
GABAergic neurotransmission. The observed anticonvulsant activity of the plant's 
extract may have been caused by complex interactions among the various chemical 
constituents of the herb. However, the findings of the present study lend 
pharmacological support to the suggested folkloric uses of the plant's root in the 
management and/or control of epilepsy and childhood convulsions in some 
communities of South Africa, and probably also account for the 'sedative' adverse 





METABOLIC PHARMACOLOGY OF HARPAGOPHYTUM 
PROCUMBENSDC 
ABSTRACT 
Harpagophytum procumbens DC is widely used in South African traditional medicine 
for the treatment, management and/or control of a variety of human ailments, 
including diabetes mellitus. In the present study, the hypoglycaemic and antidiabeticic 
effects of the plant's root extract have been investigated in rats using chlorpropamide 
(250 mg/kg p.o.) as reference hypoglycaemic agent for comparison. Harpagophytum 
procumbens secondary root aqueous extract (HPE, 50-800 mg/kg i. p.) produced 
dose-dependent, significant reductions (P<0.05-0.001) in the blood glucose 
concentrations of both fasted normal and fasted diabetic rats. The results of this 
experimental animal study indicate that Harpagophytum procumbens secondary root 
aqueous extract possesses hypoglycaemic/antidiabetic activity. These observations 
lend pharmacological support to the suggested folkloric uses of Harpagophytum 
procumbens secondary root in the management and/or control of adult-onset, type-2 
diabetes mellitus in some communities of South Africa. 
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INTRODUCTION 
In the form of infusions, decoctions, tinctures, powders and extracts, the dried thick, 
fleshy, tuberous secondary tap roots of Harpagophytum procumbens are usually used 
in South African traditional medicine for a variety of human ailments, including 
diabetes (Watt and Breyer-Brandwijk, 1962; Van Wyk and Gericke, 2000; Van Wyk 
et ai., 2002; Van Wyk and Wink, 2004). However, there is no record or report 
whatsoever in the literature on the hypoglycaemic/antidiabetic activity of 
Harpagophytum procumbens secondary root extract. In an effort to scientifically 
appraise the 'healing powers' and medicinal value of Harpagophytum procumbens in 
diabetes, the present study was undertaken to investigate the antidiabetic property of 
the plant' s secondary root aqueous extract in an experimental model of diabetes 
mellitus. 
MATERIALS AND METHODS 
Plant Material 
The plant material used in this study, its preparation and extraction, are the same as 
those described in detail under Chapters Two, Three and Four ofthis Thesis. 
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Animal Material 
Young adult Wistar rats (Rattus norvegicus) weighing 250-300 g were used. The 
animals were kept and maintained under laboratory conditions of temperature, 
humidity, and light; and were allowed free access to food (standard pellet diet) and 
water ad libitum. The animals were divided into drug-treated 'test' and distilled 
water-treated 'control' groups of 8 animals per group. All the animals were fasted for 
12 hours, but still allowed free access to water, before the commencement of our 
experiments. It has been shown that oral administration and subsequent passage of 
Harpagophytum procumbens root extract through the stomach (where the pH is 
acidic) leads to loss of pharmacological activity of the extract - due to deactivation of 
its active constituents by gastric acid juices (Soulimani et ai., 1994). In the present 
study, therefore, Harpagophytum procumbens root aqueous extract has been 
administered intraperitoneally, a route that ensures adequate systemic bioavailability 
and pharmacological activity of the extract. 
Determination of Blood Glucose Levels 
Young adult Wistar rats (Rattus norvegicus) weighing 250-300 g were used. The 
animals were randomly divided into two (A and B) groups of 'test' and 'control' rats. 
Diabetes mellitus was induced (in Group A diabetic 'test' rats) by intraperitoneal 
injections of streptozotocin (STZ, 90 mg/kg). Diabetes was allowed to develop and 
stabilize in these STZ-treated rats over a period 3 to 5 days. The 'control' (Group B) 
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normal (normoglycaemic) rats were treated with distilled water (2 ml/kg i. p.) only. 
All the animals were kept and maintained under laboratory conditions of temperature, 
humidity and light (12-hour day:12-hour night cycle); and were allowed free access to 
food (standard pellet diet) and water ad libitum. Before the commencement of our 
experiments, both the 'control' normal (normoglycaemic) and STZ-treated 'test' 
diabetic (hyperglycaemic) rats were fasted for 12 hours, but still allowed free access 
to water throughout. Fasted STZ-treated rats with blood glucose concentrations ~ 500 
mg/dL were considered to be diabetic, and used in this study. At the end of the 12-
hour fasting period [taken as zero time (i. e., 0 hour)] blood glucose levels (initial 
glycaemia - Go) of the fasted normal (normoglycaemic) and STZ-treated, diabetic rats 
were determined and recorded. For both the normoglycaemic and hyperglycaemic 
animals, chlorpropamide (250 mg/kg p.o.) was used as the reference hypoglycaemic 
agent for comparison. The test compounds [i. e., Harpagophytum procumbens root 
aqueous extract (HPE, 50-800 mg/kg i. p.) and chlorpropamide (250 mg/kg p.o.)] 
were administered to the groups of fasted normal and fasted diabetic 'test' rats. 1,2,4 
and 8 hours following administration of the 'test' compounds to the animals, blood 
glucose concentrations (Gt) were determined. The rats were restrained in a cage, and 
blood samples (0.02 ml) were collected from the tail tip vein of each rat for blood 
glucose analysis. Blood samples were obtained by repeated puncture of the same tail 
tip vein. Blood glucose concentrations were determined by means of Bayer's 
Glucometer Elite® and compatible blood glucose test strips. Percentage glycaemic 
variation was calculated as a function of time (t) by applying the formula: 
% glycaemic change = Go - Gt X 100 / Go 
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where Go and Gt represent (zero time or 0 hour) glycaemic values before, and 
glycaemic values at 1, 2, 4 and 8 hours after, intraperitoneal (or oral - in the case of 
chlorpropamide) administrations of the 'test' compounds respectively. At the same 
time, rats treated with distilled water (2 mllkg i. p.) alone were used as ' controls'. 
The 'test' and 'reference' compounds used in all experiments contained in this study 
[i. e., Harpagophytum procumbens root aqueous extract (HPE) and chlorpropamide] 
were dissolved in distilled water on each day of our experiment. In all cases, the 
vehicle (i. e., distilled water) was used as ' control' for the 'test' and 'reference' 
compounds used. 
Data Analysis 
Data obtained were pooled and presented as means (±SEM). Data from 'control ' rats 
were used as baseline values. The differences between the plant extract- or 
chlorpropamide-treated ' test' rats, and distilled water-treated ' control' animals, were 
analysed statistically. The data were subjected to one-way analysis of variance 
(ANOYA), and Scheffe' s multiple comparison was used to determine the level of 
significance of the differences between the 'test' and ' control' group data. Yalues ofP 




In a separate set of experiments involving 12-hour fasted normal and STZ-treated 
diabetic rats, the mean blood glucose level of normal (normoglycaemic) rats was 
found to vary between 104±5.50 and 108±5.45 mg/dL. In the 'control' set of 
experiments, pre-treatment of the animals with distilled water (2 mllkg i. p.) alone did 
not significantly modify (P>0.05) the blood glucose concentrations of either the fasted 
normal, or fasted diabetic rats. In these animals, pre-treatment with distilled water (2 
ml/kg i. p.) for I, 2, 4 and 8 hours either slightly but insignificantly (P>0.05) 
decreased, increased, or did not affect at all, the blood glucose concentrations of the 
fasted 'control' animals. The distilled water-induced changes in the blood glucose 
levels of the fasted rats varied by values ranging between 0.1 % and 1.0% of the mean 
basal blood glucose concentrations. However, compared with the distilled water-
treated 'control' rats, pre-treatment of the fasted animals with relatively moderate to 
high doses of Harpagophytum procumbens root aqueous extract (HPE, 50-800 mg/kg 
i. p.) produced significant reductions (P<0.05-0.001) in the blood glucose 
concentrations of both fasted normal and fasted diabetic rats (Tables 8 and 9). The 
maximal reductions in the blood glucose concentrations of the fasted 'test' rats 
occurred at the plant extract dose of 800 mg/kg (i. p.). Pre-treatment of fasted normal 
(normoglycaemic) and STZ-treated diabetic rats with chlorpropamide (250 mglkg p. 
0.) or with Harpagophytum procumbens root aqueous extract (HPE, 800 mg/kg i. p.) 
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for 1,2, 4 and 8 hours also produced highly significant reductions (P <0.01-0.001) in 
the blood glucose concentrations ofthe animals (compared with distilled water-treated 
fasted 'control' rats - see Tables 8 and 9). The hypoglycaemic effect of the plant's 
root aqueous extract became significant (P<0.05) 1 hour following oral 
administration, reaching the peak of its hypoglycaemic effect 2-4 hours after 
administration. However, the hypoglycaemic effect of the plant' s extract was still 
significant 8 hours after intraperitoneal administration of the extract (see Tables 8 and 
9). Thereafter, the blood glucose concentrations of the animals gradually returned to 
normal, baseline values at the end of the 24th hour. 
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Table 8. 
Effects of Harpagophytum procumbens root aqueous extract (HPE, 800 mglkg i. p.) and chlorpropamide (250 mglkg p.o.) on blood 
glucose concentrations (mg/dL) of normal (normoglycaemic) rats. Values given represent the mean (±SEM) of8 observations. 
Before % 
Treatment Treatment After Treatment Maximal Maximal 
Reduction Reduction 
o hr 1 hr 2 hr 4 hr 8 hr 
Control (2 ml/kg i. p. 105.50±4.56 106.15±4.51 105.55±4.35 104.86±4.50 105.28±4.35 0.64 0.61 
distilled water) 
HPE (800 mglkg i. p.) 107.35±4.50 101.45±4.45* 90.56±4.30** 79.75±4.35*** 92.81±4.51 ** 27.60*** 25.71 *** 
Chlorpropamide 106.40±4.45 96.45±4.48** 78.53±4.50*** 69.50±4.38*** 80.63±4.56*** 36.90*** 34.68*** 
(250 mg/kg p.o.) 
*P < 0.05; **p < 0.01; ***p < 0.001 vs Control 
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Table 9. 
Effects of Harpagophytum procumbens root aqueous extract (HPE, 800 mglkg i. p.) and chlorpropamide (250 mglkg p.o.) on 
blood glucose concentrations (mg/dL) of STZ-treated, diabetic rats. Values given represent the mean (±SEM) of 8 
observations. 
Before % 
Treatment Treatment After Treatment Maximal Maximal 
Reduction Reduction 
o hr 1 hr 2 hr 4 hr 8hr 
Control (2 rnl/kg i. p. 
distilled water) 550.48±52.41 548.45±56.45 551.45±50.57 547.56±55.48 550.21±54.45 2.92 0.53 
HPE (800 rng/kg i. 560.52±55.46 470.53± 54.50* 387.65±53.55* 282.60±54.45*** 364.59±50.41 ** 277.92*** 49.58*** 
p.) * 
Chlorpropamide 
(250 rnglkg p.o.) 555.50±51.45 448.54±50.52* 347.50±51.56* 230.61±52.41 *** 290.51±53.40** 324.89*** 58.49*** 
* 
*P < 0.05; **p < 0.01; ***p < 0.001 vs Control 
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DISCUSSION 
It has been reported that oral administration and subsequent passage of Harpagophytum 
procumbens root extract through the stomach (where the pH is acidic) leads to loss of 
pharmacological activity of the plant's extract - due to deactivation of its active 
constituents by gastric acid juices (Soulimani, et al., 1994). In the present study, 
therefore, the root aqueous extract of Harpagophytum procumbens used has been 
administered intraperitoneally, a route that ensures high systemic bioavailability and 
adequate pharmacological activity of the extract. 
Experimental evidence obtained in the present study shows that Harpagophytum 
procumbens secondary root extract (HPE, 50-800 mg/kg i. p.) dose-dependently and 
significantly (P<0.05-0.001) reduced the blood glucose concentrations of fasted normal 
and fasted STZ-treated diabetic rats. The main classes of synthetic oral hypoglycaemic 
agents currently available for the management and/or control of adult-onset, type-2, non-
insulin-dependent (NIDDM) diabetes mellitus include the sulphonylureas, biguanides, 
thiazolidinediones, alpha-glucosidase inhibitors, and so on. Chlorpropamide, used as the 
reference hypoglycaemic agent in this study, is a member of the 'first-generation 
sui phony lure as ' . As a class, sulphonylureas stimulate and increase the release of 
endogenous insulin from pancreatic p-cells. They also promote and facilitate peripheral 
tissue uptake and utilization of glucose. It has been proposed (Jackson and Bressler, 
1981) that sulphonylureas produce their hypoglycaemic effects via three main 
mechanisms, viz: (i) increased insulin release from pancreatic ~cells - sulphonylureas 
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bind to pancreatic receptors associated with potassium (K+) channels on the surface of the 
pancreatic p-cells. This binding inhibits K+ efflux from the p-cells through the K+-
channels. Consequently, depolarization of pancreatic p-cells ensues. This depolarization 
opens the 'voltage-gated' calcium (Ca2+) channels. This process allows and/or facilitates 
Ca2+ influx into the pancreatic p-cells, subsequently resulting in the release of preformed 
insulin from pancreatic p-cells; (ii) potentiation of insulin's action on target tissues and 
increased glucose removal from the blood - sulphonylureas increase the binding of 
insulin to peripheral tissue insulin receptors, thereby enhancing glucose uptake and 
utilization by peripheral tissues; (iii) reduction of blood glucagon levels - administration 
of sulphonylureas may lead to reduced blood glucagon concentrations. This effect can be 
attributed, at least in part, to the hypoglycaemic action of sulphonylureas, since the 
primary actions of glucagon are to enhance the metabolism of stored glycogen, and to 
facilitate and/or increase gluconeogenesis and ketogenesis. Enhanced release of insulin 
(and somatostatin) inhibits glucagon secretion via inhibition of pancreatic a-cell 
secretion. Thus, any plant product or chemical constituent that is capable of affecting the 
pancreatic p- or a-cell secretion in any of the three ways illustrated above will be a good 
mimicker of sulphonylureas, and will produce hypoglycaemic effects in mammals via 
mechanisms similar to those of sulphonylureas. 
Since streptozotocin is known to destroy insulin-producing pancreatic p-cells, the STZ-
treated rat model would appear to represent a good laboratory NIDDM experimental 
diabetic state, with residual or remnant insulin production by the pancreatic p-cells. The 
diabetic state of STZ-treated diabetic rats is, therefore, not the same as that obtained by 
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total pancreatectomy, as daily administration of insulin is not required for survival in 
STZ-treated diabetic animals. Acute treatment of the 'control' rats with distilled water 
alone did not produce any significant change in the blood glucose concentrations of either 
the fasted normal or the fasted STZ-treated, diabetic rats. However, the aqueous plant's 
extract, like chlorpropamide - a sulphonylurea antidiabetic agent - produced significant 
reductions in the blood glucose levels of the fasted normal and fasted STZ-treated 
diabetic rats. The hypoglycaemic and antidiabetic effects of Harpagophytum procumbens 
root aqueous extract would, therefore, appear to be most probably exerted via a 
mechanism that is similar to that of chlorpropamide. 
Harpagophytum procumbens roots have been reported to contain sugars, flavonoids, 
iridoid glycosides, phenolic acids, quinones, phytosterols, triterpenoids, acetoside esters 
and minerals (Watt and Breyer-Brandwijk, 1962; Van Wyk and Gericke, 2000; Van Wyk 
et aI., 2002). Although the exact chemical constituent/s of H procumbens roots that is/are 
responsible for the observed hypoglycaemic effects of the plant's aqueous extract still 
remains speculative, several investigators have attributed the anti-inflammatory and 
hypoglycaemic properties of a number of plants to their triterpenoid, coumarin and 
flavonoid constituents (Gupta et a!., 1969; Singh et at., 1992; Akah and Okafor, 1992; 
Liu, 1995; MarIes and Farnsworth, 1995; Ojewole, 2002; 2003; Adzu et ai., 2003). 
The experimental evidence obtained in the present laboratory animal study indicates that 
aqueous root extract of H procumbens possesses hypoglycaemic/antidiabetic property. 
This pharmacological action may be due to complex interactions among the various 
chemical constituents of the plant. However, the findings of this study lend 
127 
pharmacological support to the suggested folkloric uses of the plant's root in the 
management and/or control of adult-onset, type-2 diabetes mellitus in some communities 




CONCLUSIONS AND RECOMMENDATIONS FOR 
FURTHER STUDY 
CONCLUSIONS 
The studies reported in this thesis clearly indicate that Harpagophytum procumbens 
secondary root aqueous extract possesses a catalogue of pharmacological actions. 
The plant's extract produced concentration-dependent, significant (P<0.05-0.00l), 
atropine-sensitive contractions of mammalian and avian isolated gastro-intestinal smooth 
muscles. The plant's extract also exhibited significant anticholinesterase activity. It is 
speculated that the contractile effects of Harpagophytum procumbens secondary root 
aqueous extract is mediated via cholinergic mechanism, possibly by stimulating 
cholinergic muscarinic receptors. The contractile effects of the herb's extract on gastro-
intestinal smooth muscles would appear to provide a pharmacological basis for the 
troublesome ' gastro-intestinal disturbance and/or upset' commonly associated with 
Harpagophytum procumbens secondary root aqueous extract medication in some 
communities of South Africa. 
Harpagophytum procumbens secondary root aqueous extract also provoked 
concentration-related, significant (P<0.05-0.001) contractions of the rat isolated uterine 
muscles. This observation appears to justify the use of the herb' s secondary root extracts 
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for induction and acceleration of labour by traditional birth attendants. The findings also 
provide pharmacological justification for the use of the plant's extract in expelling 
retained placentas during child birth. The uterotonic action of Harpagophytum 
procumbens secondary root aqueous extract is thought to be due to the release of 
uterotonic mediators, such as prostaglandins, polypeptide kinins, acetylcholine, and so 
forth. However, because Harpagophytum procumbens secondary root aqueous extract 
induced powerful contractions of uterine muscle strips taken from both pregnant and non-
pregnant rats, the use of the plant's extract should be contra-indicated and avoided in 
pregnant women. 
Harpagophytum procumbens secondary root aqueous extract produced a dose-related, 
slight but significant (P<O.05-0.00l) hypotension in the arterial blood pressure of 
anaesthetized rats. The depressor effect of the plant's extract on the blood pressure of rats 
in vivo was resistant to atropine and mepyramine pretreatment. It is thought that the 
depressor effect could be due in part, to the vasorelaxant activity of the plant's extract, 
since Harpagophytum procumbens secondary root aqueous extract produced 
concentration-related, significant, secondary longer-lasting relaxations of the rat isolated 
portal vein. 
The plant's extract produced biphasic effects on guinea-pig isolated cardiac muscles. The 
responses of guinea-pig isolated atrial muscles to the plant's extract consisted of 
concentration-dependent, initial slight positive inotropic and chrotropic effects followed 
by long-lasting, significant negative inotropic and chronotropic effects. It was observed 
that relatively high concentrations of Harpagophytum procumbens secondary root 
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aqueous extract (HPE, 400-1 000 ~g/ml) always induced concentration-related, highly 
significant (P<0.01-0.001) negative inotropic and chronotropic responses of the guinea-
pig isolated atrial muscles. 
Harpagophytum procumbens secondary root aqueous extract dose-dependently delayed 
the reaction time in the 'hot-plate' analgesic test model, and also significantly (P<0.5-
0.001) reduced or inhibited the writhes produced by 0.2 ml of 3% acetic acid in mice. In 
the two analgesic test methods used, the plant's extract produced dose-related analgesic 
effects. Although to a smaller extent, the analgesic effects of the plant's extract were 
comparable with those of morphine, diclofenac or aspirin. It is, therefore, suggested that 
the analgesic effects of plant's extract are probably mediated centrally and peripherally. 
Harpagophytum procumbens secondary root aqueous extract also produced dose-related, 
significant (P<0.5-0.001) anti-inflammatory activity against fresh egg albumin-induced 
inflammation in rats. Although qualitatively and quantitatively less, the anti-
inflammatory effect of the plant's extract was comparable with that of diclofenac or 
aspirin. It is speculated that the plant's extract probably acts via a mechanism similar to 
those of the non-steroidal anti-inflammatory drugs (NSAIDs), i. e., by inhibiting cyclo-
oxygenase and/or lipoxygenase, and thereby preventing the synthesis and release of 
inflammatory mediators such as prostaglandins. 
In mice, Harpagophytum procumbens secondary root aqueous extract significantly 
delayed (P<0.5-0.001) the onset of seizures induced by pentylenetetrazole, picrotoxin 
and bicuculline. Since pentylenetetrazole- and picrotoxin-induced seizures are known to 
occur as a consequence of inhibition or attenuation of GABA neurotransmission and/or 
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activity, it is speculated that the anticonvulsant activity of Harpagophytum procumbens 
secondary root aqueous extract might be due to potentiation or enhancement of GABA 
neurotransmission and/or activity by the plant's extract. 
Harpagophytum procumbens secondary root aqueous extract produced dose-related, 
significant reductions in the blood glucose concentrations of streptozotocin-induced 
diabetic rats. The plant's extract also reduced the glucose levels of normal 
(normoglycaemic) rats. Although smaller, the hypoglycaemic and antidiabetic effects of 
the plant's extract are comparable to those of chlorpropamide in the experimental animal 
model used. It is speculated that Harpagophytum procumbens secondary root aqueous 
extract might be producing its hypoglycaemic and antidiabetic effects via mechanisms 
similar to those of sulphonylureas. 
SUGGESTIONS FOR FURTHER STUDY 
Although evidence from the present study indicates that Harpagophytum procumbens DC 
secondary root aqueous extract possesses a battery of pharmacological actions, the 
mechanisms via which the pharmacological effects are produced still remain largely 
speculative. For example, the plant's extract has been shown to produce contractile 
effects on isolated gastro-intestinal and uterine smooth muscles of mammalian 
experimental animals. The plant' s extract has also been shown to possesses both cardio-
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tonic and cardio-depressant activities. The mechanisms of action of the plant's extract on 
the various smooth and cardiac muscle preparations used need to be probed further and 
established. 
The pharmacological actions of the plant's extract on skeletal muscles were not 
investigated in the studies reported in this thesis. It will be interesting to know what 
Harpagophytum procumbens DC secondary root aqueous extract does to mammalian 
skeletal muscles in vitro and in vivo. 
134 
REFERENCES 
1. Adzu, B., S. Amos, S. D. Kapu and K. S. Gamaniel (2003): Anti-inflammatory 
and antinociceptive effects of Sphaeranthus senegalensis. Journal of 
Ethnopharmacology, 84: 169-173. 
2. Akah, P. A. and C. L. Okafor (1992): Blood sugar lowering effect of Vernonia 
amygdalina (Del) in an experimental rabbit model. Phytotherapy Research, 6: 
171-173. 
3. AI-Tuwaijri, A. S. and A. A. Mustafa (1992): Verapamil enhances the inhibitory 
effect of diclofenac on the chemiluminescence of human polymorphonuclear 
leukocytes and carrageenan-induced rat's paw oedema. International Journal 
ofImmunopharmacology, 14: 83-91. 
4. Amabeoku, G. J. and O. Chikuni (1993): Cimetidine-induced seizures in mice: 
Antagonism by some GABAergic agents. Biochemical Pharmacology, 46(12): 
2171-2175. 
5. Amabeoku, G. J., M. J. Leng and 1. A. Syce (1998): Antimicrobial and 
anticonvulsant activities of Viscum capense. Journal of Ethnopharmacology, 61: 
237-241. 
135 
6. Bennett, P. N. and M. J. Brown (2003): Clinical Pharmacology. Nineth Edition, 
Churchill Livingstone, Edinburgh, pp. 392-404. 
7. Beresford, T. (2002): The Chemistry and Pharmacology of Harpagophytum 
procumbens. Australian Naturopathic Network, pp. 1-7. 
8. Bienvenu, E., G. J. Amabeoku, P. K. Eagles, G. Scott and E. P. Springfield 
(2002): Anticonvulsant activity of aqueous extract of Leonotis leonurus. 
Phytomedicine, 9: 217-223. 
9. Brooks, P. M., W. Hill and R. Geddes (1980): Diclofenac and ibuprofen in 
rheumatoid arthritis and osteoarthritis. Medical Journal of Australia, 1: 29- 30. 
10. Bunag, R. D. (1984): Experimental and Genetic Models of Hypertension. In: 
'Handbook of Hypertension', W. H. Birkenhager and J. 1. Reid eds., Volume 
4, Elsevier, Amsterdam, New York & Oxford; pp. 1-12. 
11. Bowman, W. C. and S. D. Everett (1964): An isolated parasympathetically-
innervated oesophagus preparation from the chick. Journal of Pharmacy and 
Pharmacology, 16(Suppl.): 72T-79T. 
136 
12. Circosta, C., F. Occhiuto, S. Ragusa, A. Trovato, G. Tumino, F. Briguglio and R. 
Costa De Pasquale (1984): A drug used in traditional medicine: Harpagophytum 
procumbens DC. II. Cardiovascular activity. Journal of Ethnopharmacology, 
11: 259-274. 
13. Costa De Pasquale, R., G. Busa, C. Circosta, L. Iauk, S. Ragusa, P. Ficarra and F. 
Occhiuto (1985): A drug used in traditional medicine: Harpagophytum 
procumbens DC. III. Effects on hyperkinetic ventricular arrhythmias by 
reperfusion. Journal of Ethnopharmacology, 13: 193-199. 
14. De Jalon, P. , 1. Bayo Bayo and M. G. De Jalon (1945): Sensible y Nuevo 
metodo de valoracion de adrenal ina en utero aislado de rata. Farmacoter. Act., 
2: 313-318. 
15. De Sarro, A., V. Cechetti, V. Fravolini, F. Naccari, O. Tabarini and G. De 
Sarro (1999): Effects of novel 6-desfluoroquinolones and classic quinolones 
on pentylenetetrazole-induced seizures in mice. Antimicrobial Agents and 
Chemotherapy, 43: 1729-1736. 
137 
16. Dongmo, A. B., A. Kamanyi, G. Dzikouk, B. Chungag-Anye Nkeh, P. V. Tan, 
T. Nguelefack, T. Nole, M. Bopelet and H. Wagner (2003): Anti-inflammatory 
and analgesic properties of the stem-bark extract of Mitragyna ciliata 
(Rubiaceae) Aubrev. & Pellegr. Journal of Ethnopharmacology, 84: 17-21. 
17. Eddy, N. D. and D. Leimback (1953): Synthetic analgesics: II. 
Dithyienylbutenylamines and dithyienylbutylamines. Journal of Pharmacology 
and Experimental Therapeutics, 3: 544-547. 
18. Ekpendu, T. 0 ., P. A. Akah, A. A. Adesomuju and J. C. Okogun (1994): Anti-
inflammatory and antimicrobial activities of Mitracarpus scaber extracts. 
International Journal of Pharmacognosy, 32: 191-196. 
19. Ellman, G. L., K. D. Courtney, V. Andres Jr. , and R. M. Featherstone (1961): 
A new and rapid colorimetric determination of acetylcholinesterase activity. 
Biochemical Pharmacology, 7: 88-95. 
20. Freeman, C., C. Johnston, C. Chew and P. Davis (1986): Effect of diclofenac 
sodium, tolfenamic acid and indomethacin on the production of superoxide 
induced by N-formyl-methionyl-Ieucyl-phenylalanine in normal human 
polymorphonuclear leukocytes. Scandinavian Journal of Rheumatology, 15: 41-
46. 
138 
21. Gale, K. (1992): GABA and epilepsy: Basic concepts from preclinical research. 
Epilepsia, 33(Suppl. 5): S3-S 12. 
22. Grahame, R. and B. V. Robinson (1981): Devil's Claw (Harpagophytum 
procumbens): Pharmacological and Clinical studies. Annals of Rheumatic 
Dideases, 40: 632. 
23. Gupta, M. B., T. N. Bhalla, G. P. Gupta, C. R. Mitra and K. P. Bhargava 
(1969): Anti-inflammatory activity of natural products: I. Triterpenoids. 
European Journal of Pharmacology, 6: 67-70. 
24. Henderson, M. and J. G. Anderson (1966): Common weeds in South Africa. 
Memoirs of the Botanical Survey of South Africa 37. 
25. Hess, S.M. and R. C. Milong (1972): In: Pow, L. E. and P. A. Ward, editors; 
Inflammation mechanism and control. New York: Academic Press; pp.I-21. 
26. Jackson, J. E. and R. Bressler (1981): Clinical pharmacology of 
sulphonylurea hypoglycaemic agents. Part I. Drugs, 22: 211-245. 
27. Koster, R., M. Anderson and E. J. De Beer (1959): Acetic acid for analgesic 
screening. Federation Proceedings, 18: 412-418. 
139 
28. Krebs, H. A. and K. Henseleit (1932): Untersuchungen uber die 
Harnstoffbildung in Tierkorper. Hoppe Seyler Z. Physiol. Chern., 210: 33-66. 
29. Lanhers, M. C., J. Fleurentin, F. Mortier, A. Vinche and C. Younos (1992): 
Anti-inflammatory and analgesic effects of an aqueous extract of 
Harpagophytum procumbens. Planta Medica, 58: 117-123. 
30. Leonard, B. E. (2000): Fundamentals of Psychopharmacology. Second Edition, 
John Wiley and Sons, London, pp. 173-184. 
31. Liu, 1. (1995): Pharmacology of oleanolic acid and ursolic acid. Journal of 
Ethnopharmacology, 49: 57-68. 
32. Mahgoub, A. A. (2002): Grapefruit juice potentiates the anti-inflammatory 
effects of dic10fenac on the carrageenan-induced rat's paw oedema. 
Pharmacological Research, 45: 1-4. 
33. MarIes, R. J. and N. R. Farnsworth (1995): Antidiabetic plants and their 
active constituents. Phytomedicine, 2: 137-189. 
34. Meldrum, B. S. (1975): Epilepsy and gamma-aminobutyric acid-induced 





35. Menasse, R., P. R. Medwall, T. Kmctz, C. Pericin, L. Riesterer, A. Sallmann 
and R. Ziel (1978): Pharmacological properties of diclofenac sodium and its 
metabolites. Scandinavian Journal of Rheumatology, 22: 5-16. 
36. Moussard, C. (1992): A Drug Used in Traditional Medicine - Harpagophytum 
procumbens: No Evidence ofNSAID-like Effect on Whole Blood Eicosanoid 
Production in Humans. Prostaglandins Leukotrienes and Essential Fatty 
Acids, 46(4): 283 - 286. 
37. Muko, K. N. and F. C. Ohiri (2000): A preliminary study on the anti-
inflammatory properties of Emilia sonchifolia leaf extracts. Fitoterapia,71: 
65-68. 
38. Navarro-Ruiz, A. , E. B. Bastidas-Ramirez, 1. Garcia-Estrada, P. Garcia-
Lopez and P. Garson (1995): Anticonvulsant activity of Casimiora edulis 
in comparison to phenytoin and phenobarbital. Journal of 
Ethnopharmacology, 45: 199-206. 
39. Nicoll, R. A. (2001): Introduction to the pharmacology of the central nervous 
system (CNS). In: "Basic and Clinical Pharmacology", Eighth Edition, B. G. 
Katzung ed. , McGraw-Hill, New York, pp. 351-363. 
141 
40. Occhiuto, F., C. Circosta, S. Ragusa, P. Ficarra and R. Costa De Pasquale 
(1985): A drug used in traditional medicine: Harpagophytum procumbens DC. 
IV. Effects on some isolated muscle preparations. Journal of Ethnopharmacology, 
13: 201-208. 
41. Ojewole, J. A. O. (1976). Studies on the Pharmacology of Some Antimalarial 
Drugs. PhD Thesis, University of Strathclyde, Glasgow, UK. 
42. Ojewole, 1. A. O. (2002): Hypoglycaemic effect of Clausena anisata (Willd) 
Hook methanolic root extract in rats. Journal of Ethnopharmacology 81: 231-
237. 
43. Ojewole,1. A. O. (2003): Evaluation of the anti-inflammatory property of 
Sclerocarya birrea (A. Rich.) Hochst. (family: Anacardiaceae) stem-bark 
extracts in rats. Journal of Ethnopharmacology, 85: 217-220. 
44. Okada, R., N. Negishi and H. Nagaya (1989): The role ofthe nigrotegmental 
GABAergic pathway in the propagation of pentylenetetrazole-induced seizures. 
Brain Research, 480: 383-387. 
45. Olsen, R. W. 1. (1981): GABA-benzodiazepine-barbiturate receptor 
interactions. Journal of Neurochemistry, 37: 1-3. 
142 
46. Oriowo, M. A. (1982): Anti-inflammatory activity of piperonyl-4-acrylic 
isobutyl- amide, an extractive from Zanthoxylum zanthoxyloides. Planta 
Medica, 44: 54-56. 
47. Rang, H. P., M. M. Dale and J. M. Ritter (2000): Pharmacology. Fourth 
Edition, Churchill Livingstone, Edinburgh, pp. 470-482. 
48. Seeger, P. C. (1973). Harpagophytum, an effective plant remedy. 
Erfahrungaheilkunde, Volume 8. 
49. Sigmeth, W. and W. Sieberer (1980): A comparision of the short-term effects 
of ibuprofen and dic10fenac in spondylosis. Journal of International Medical 
Research, 6: 369-374. 
50. Silva, 1., W. Abebe, S. M. Sousa, V. G. Duarte, M. 1. Machado and F. 1. 
Matos (2003): Analgesic and anti-inflammatory effects of essential oils of 
eucalyptus. Journal of Ethnopharmacology, 89(2-3): 277-283. 
51. Singh, G. B., S. Singh, S. Bani, B. D. Gupta, and S. K. Banerjee (1992): Anti-
inflammatory activity of oleanolic acid in rats and mice. Journal of Pharmacy 
and Pharmacology, 44: 456-458. 
143 
52. Siraux, P. (1977): Diclofenac (voltaren®) for the treatment of osteoarthritis: A 
double-blind comparison with naproxen. Journal of International Medical 
Research, 5: 169-174. 
53. Skoutakis, V. A., C. A. Carter, T. R. Mickle, V. H. Smith, C. R. Arkin, 1. 
Alissandratos and D. E. Pretty (1988): Review of diclofenac and evaluation 
of its place in therapy as a non-steroidal anti-inflammatory agent. Drug 
Intelligence and Clinical Pharmacy, 22: 805-859. 
54. Small, R. E. (1989): Drug reviews: Diclofenac sodium. Clinical Pharmacy, 8: 
545-558. 
55. Smith, M., 1. Goliath, E. Jefthas, P. Langenhoven, W. Letchamo and 1. Simon 
(2001): ASNAPP-DCFS-I0: Agribusiness in Sustainable African Plant Products. 
Devil's Claw, pp. 1 - 2. 
56. Snedecor, G. W. and W. G. Cochrane (1967): Statistical Methods. 6th Edition; 
Ames, Iowa: The Iowa State University Press; USA. 
144 
57. Soulimani, R., C. Younos, F. Mortier and C. Derrieu (1994): The role of 
stomachal digestion on the pharmacological activity of plant extracts, using 
as an example, extracts of Harpagophytum procumbens. Canadian Journal of 
Physiology and Pharmacology, 72(12): 1532-1536. 
58. Taesotiku, T., A. Panthong, D. Kanjanapothi, R. Verpoorte and 1. 1. C. 
Scheffer (2003): Anti-inflammatory, antipyretic and antinociceptive 
activities of Tabernaemontana pandacaqui Poir. Journal of 
Ethnopharmacology, 84: 31- 35. 
59. Van Wyk, B-E. and N. Gericke (2000): People's Plants. A Guide to Useful 
Plants of Southern Africa. 1 st Edition, Briza Publications, Pretoria; p.146. 
60. Van Wyk, B-E and M. Wink (2004): Medicinal Plants of The World. 1st 
Edition, Briza Publications, Pretoria, p. 165. 
61. Van Wyk, B-E., B. Van Oudtshoorn and N. Gericke (2002): Medicinal 
Plants of South Africa, 2nd Edition, Briza Publications, Pretoria; p. 144. 
62. Vellucci, S. V. and R. A. Webster (1984): Antagonism of caffeine-induced 
seizures in mice by Ro 15-1788. European Journal of Pharmacology, 97: 
289-295. 
145 
63. Watt, J. M. and M. G. Breyer-Brandwijk (1962): The Medicinal and 
Poisonous Plants of Southern and Eastern Africa. 2nd Edition, Livingstone, 
London; p. 830. 
64. Whitehouse, L. W. (1983): Devil's Claw: No evidence for anti-inflammatory 
activity in the treatment of arthritic disease. Canadian Medical Association 
Journal, 129(3): 249-251. 
65. WHO (2003): http:/www.afro.who.intlpress/periodicals/afronews/jan-feb 2003. 
66. WHO (2002): WHO Traditional Medicines Strategy (2002 - 2005). 
WHOIEDMlTRMl2002.1. Geneva. 
67. Williamson, E. M., D. T. Okpako and F. 1. Evans (1996): Pharmacological 
Methods in Phytotherapy Research. Volume 1. Selection, Preparation and 
Pharmacological Evaluation of Plant Materials. John Wiley, London, 
pp.184-186. 
68. Zakaria, M. N., M. W. Islam, R. Radhakrishnan, H. B. Chen, M. Kamil, A. N. 
AI-Gifri and A. Chan-Attas (2001): Antinociceptive and anti-inflammatory 





ETHICAL CLEARANCE AND ETHICAL ISSUES 
The experimental protocols used in this thesis was approved by the Ethics Committee of 
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subjected to deep petroleum ether inhalation before they were bled out. 
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APENDIX II 
PLANT MATERIAL USED 
Fresh pieces of Harpagophytum procumbens DC secondary roots were purchased from 
Upington 'Muthi' Market in the Northern Cape Province of South Africa (between 
November, 2001 and March, 2003). The roots were identified by the staff of the North-
West University's Botany Department as the secondary roots of Harpagophytum 
procumbens DC [family: Pedaliaceae]. Voucher specimen of the plant's secondary roots 
have been deposited in the University's Herbarium. 
Preparation of Harpagophytum procumbens Root Aqueous Extract 
One kilogramme (1 kg) of fresh secondary roots of H procumbens were sliced and air-
dried at room temperature. The sliced, air-dried roots of the plant were ground into fine 
powder in a Waring commercial blender. The powder was Soxhlet extracted twice, on 
each occasion with 2.5 litres of distilled water at room temperature for 24 hours with 
shaking. The combined aqueous extracts were filtered and concentrated to dryness under 
reduced pressure at 30±1°C. The resulting aqueous extract was freeze-dried, finally 
giving 15.56 g [i. e., 1.556% yield] of a light-brown, powdery crude aqueous root extract 
of Harpagophytum procumbens secondary root. Aliquot portions of the crude root 
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aqueous extract residue were weighed and dissolved In distilled water for use on 




The following compounds, chemicals, reagents and drugs were used: 
Harpagophytum procumbens secondary root extract (HPE); pentobarbitone sodium 
(Abbot Laboratories); phenobarbitone sodium (Sigma); acetylthiocholine; (-)-
acetylcholine chloride (Sigma); pentylenetetrazole, picrotoxin, bicuculline (Sigma); 
morphine (Bodene); diazepam (Roche); aspirin (sny. acetylsalicylic acid), diclofenac 
(Sigma); acetic acid (Merk); (-)-noradrenaline hydrochloride, chlorpropamide (Sigma); 
atropine sulphate, reserpine, 5,5-dithiobis-2-nitrobenzoic acid, histamine dihydrochloride, 
physostigmine sulphate, tyramine hydrochloride, nicotine hydrogen tartrate, 
stilboesterol, potassium chloride (British Drug Houses); phentolamine mesylate (Ciba); 
5-hydroxytryptamine (Koch-Light); heparin (Evan Medical); hexamethonium bromide, 
mepyramine maleate, (May and Baker); oxytocin (Park-Davis); indomethacin (Merck, 
Sharp and Dohme); petroleum ether (Saarchem) and streptozotocin (Fluka). 
Except where otherwise indicated, HPE and all drugs used were dissolved in distilled 
water. Distilled water was used as the 'control' vehicle (solution) in all experiments. 
Drug concentrations quoted in the in vitro studies refer to the final organ-bath 
concentrations. 
In the in vivo experiments, pilot (preliminary) studies were carried out to establish the 
final doses of HPE and other drugs used, and also to determine pretreatment times. 
Solutions of HPE and other drugs used were prepared on each day of the experiment. 
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APENDIX IV 
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